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Abstract 
 
Introduction 
Infection associated with dental implants is the most common cause of their failure. 
The aim of this study was to discover a new coating for dental implants that has a 
good antibacterial and antibiofilm activity against an early colonizer on implant 
surfaces: Streptococcus sanguinis. Furthermore, the coating should have a good 
biocompatibility with bone.  
Methods 
Different coatings were prepared on the surface of titanium alloy (Ti4Al6V) discs. 
Silver, titanium dioxide, and hydroxyapatite nanoparticles, as well as hydroxyapatite 
microparticles were used to coat titanium discs. Three techniques were used to coat 
the titanium discs; (i) Solution deposition and heating for hydroxyapatite micro and 
nanoparticles, (ii) silver plating, and (iii) anodization to coat the discs with titanium 
dioxide. The antibacterial effect of these coating was investigated against the 
clinically relevant microbe, Streptococcus sanguinis. End point assays such as 
lactate production and a live/dead staining kit were used to check for bacterial 
growth inhibition. The bacterial growth was also qualitatively assessed by scanning 
electron microscopy. The total concentration of silver, calcium and phosphorus in the 
media was measured to check the stability of the coatings. Then the biocompatibility 
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of the coatings with good antibacterial activity was evaluated using primary human 
osteoblast cells; toxicity assays such as lactate dehydrogenase leak and cell protein 
concentration were used for this purpose. The total concentration of silver and 
electrolytes (K+ and Na+) were measured in the media and in the cell homogenates. 
Uncoated titanium discs were used as a control group in both experiments. 
Results   
This study revealed that silver plus hydroxyapatite nanoparticles (Ag+nHA) and silver 
plus hydroxyapatite microparticles (Ag+mHA) coatings have an excellent 
antibacterial activity against S. sanguinis compared to uncoated titanium discs. , This 
observation was  also confirmed by SEM images. Furthermore, the stability of the 
coating was confirmed by ICP-MS measurement, as the silver release from these 
two coatings was low (<0.5 mg/l). However, the biocompatibility test showed that 
these coatings reduced the viability of osteoblast cells, as measured by  less LDH 
activity and alkaline phosphatase activity in the cell homogenates compared to the 
control. The activity of these enzymes in the cell homogenates was about 75 % 
lower than the control. In addition, the silver ion release from these coatings into the 
cell culture media (DMEM) was 30-fold higher compared to the silver release in the 
bacterial test. 
Conclusion  
The antibacterial activity of Ag+nHA and Ag+mHA coatings was confirmed against 
Streptococcus sanguinis. These coatings could be of great use clinically to prevent 
the bacterial infection of dental implant. However, this study raise concerns 
regarding the biosafety of silver-releasing implantable materials, because they may 
compromise the biocompatibility of the bone cells in certain conditions. Hence, more 
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investigations are needed to ensure the biocompatibility of these two coatings before 
their clinical application. 
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Introduction and Literature review  
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1.1  
 
Recently, the use of dental implants for replacing missing teeth has increased. 
Dental implants are biocompatible materials that are surgically inserted into the jaw 
bone underneath the gingiva in order to support artificial crowns (Oshida et al., 
2010). Titanium and its alloy (Ti6Al4V) are the most common bulk materials that are 
used in dental implants, because of their good biocompatibility, mechanical strength, 
and corrosion resistance (Williams, 1977; Zhao et al., 2009; Norowski, 2009). The 
first uses of titanium and titanium alloy as medical implants date back to 1971; based 
on the results of research showing that titanium can attach to the bone firmly (Pye et 
al., 2009). Despite clinical success, dental implants have a number of problems in 
their use. Common problems are infections associated with the implants (peri-
implantitis) and inadequate osseointegration (i.e., difficulty in obtaining good bone-
implant contact) (Tomsia et al., 2011). Several attempts have been made to solve 
the current implant issues, such as modification of the implant surfaces, or coating 
the surfaces with different bioactive materials (Wan et al., 2007; Svanborg et al., 
2011; Kazemzadeh-Narbat et al., 2013).  
Nanotechnology has been used to improve the success rate of dental implants. 
This may be achieved by producing nano-sized structures that could improve the 
osteointegration and decrease infection associated with dental implants (Meirelles et 
al., 2008; Tomsia et al., 2011). Nanotechnology can be defined as a science that 
deals with manufacturing of the nanomaterials. Nanomaterials can be defined as 
“Any form of a material that is composed of discrete functional parts, many of which 
have one or more dimensions of the order of 100 nm or less” (Lövestam et al., 
2010). Nanomaterials have unique physical, chemical and biological properties. This 
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is partly because of two factors; an increase in the surface area/volume of the 
material, and unusual physico-chemical properties such as quantum effect that may 
appear at the nano scale (Kanaparthy et al., 2011). Nanomaterials are widely applied 
in medical and dental fields in areas such as drug and gene delivery, diagnostics 
(Sahoo et al., 2007; Howes, 2014; Goenka, 2014); as well as their use in medical 
implants (Liu, 2007). 
1.2 Infections associated with dental implants (peri-implantitis) 
 
Biomaterials have been used widely in medicine to restore the functions of body 
parts such as heart valves, orthopedic and dental implants (Langer et al., 2004). 
However, the infections associated with biomaterials might cause serious 
complications for some patients (Harris et al., 2006; De Giglio, 2013). For example, 
infections can lead to the surgical removal of the dental implant (Subbiahdoss et al., 
2009; Sivolella et al., 2012). The rate of the infectious complication of implants that 
requires surgical removal is approximately 5-10 % of patients (Maathuisa, 2007). In 
addition to the effect of bacteria on the tissues, bacteria have an effect on the 
biomaterials as well. Bacteria can reduce the durability of the titanium alloy used in 
implants, because of the production of pitting corrosion on the exposed surface of 
titanium in physiological conditions (Gil et al., 2012).  
Peri-implantitis is a condition that can be identified as an inflammation of the 
tissues surrounding the implant and causes bone resorption (Albrektsson et al., 
1994). Dental implants are partially exposed to the oral environment because of their 
transgingival abutment. Hence the gingival part of implants has a pivotal role in 
bacterial entry and infections (Juan et al., 2010). There are two main causes of peri-
4 
 
implantitis, biofilm formation on the surface of implant and decrease of the immune 
response at the implant-tissue interface (Zhao et al., 2009).  
The biocompatibility of titanium is dependent on the formation of a protein layer 
on the surface of the titanium. However, this protein layer on the titanium surface 
enhances bacterial colonization and biofilm formation (Harris et al., 2006). Biofilms 
are complex communities of host cells and microbes attached to a substratum, and 
consists of cells irreversibly attached to the surface, with the cells embedding in 
extracellular polymeric substances that are produced by the cells as the biofilm 
develops (Donlan et al., 2002). The biofilm protects the microbes from environmental 
conditions such as dehydration, biocides, and also enhances bacterial growth 
(Dunne et al., 2002). Bacteria in the biofilm may become more resistant to host 
defenses and need almost 1000-times the antibiotic dose that inhibits the same 
bacteria in suspension (Vasilev et al., 2009). Thus, it is difficult to treat peri-
implantitis with common systemic antibiotics (Zhao et al., 2009). The micro-
organisms that cause peri-implantitis are very similar to those that cause chronic 
periodontitis; the predominant strains are; Porphyromonas gingivalis, Prevotella 
intermedia, Veillonella species and Treponema denticola. Candida species such as 
Candida albicans are also isolated from peri-implant lesion which is uncommon in 
periodontitis (Leonhardt et al., 1999). One of the early colonizers on the surface of 
implants is Streptococcus sanguinuis. This species provides a favorable condition for 
the more pathogenic species to grow in the biofilm (Größner-Schreiber et al., 2001).  
The other cause of peri-implantitis is the impaired immunological response at the 
site of the implant, as surgical trauma compromises the local immune defense at the 
implant site, especially at the early stage of implantation. Hence patients will be more 
prone to infection at this stage of implantation. Even after the healing phase, the 
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immune response remains impaired at the implant-tissue interface on account of the 
small number of blood vessel in the surgical zone (Zhao et al., 2009).  
In addition to peri-implantitis, there is another type of infection that is associated 
with dental implants which is peri-implant mucositis. The latter condition can be 
defined as the infection of the soft tissues overlying dental implants, which is 
considered as one of the causes of peri-implantitis; and consequently bone loss 
(Jovanovic, 1993). One of the common causes of peri-implant mucositis is an 
accumulation of debris around the suture during the healing period, which provides a 
favorable environment for bacteria. Mucositis is a reversible inflammation (Mombelli 
et al., 1998) and its prognosis is better than peri-implantitis (Meffert, 1994).  
  Many therapeutic methods are used to treat peri-implantitis such as, 
conventional mechanical debridement, using local antibiotic and antimicrobial agents 
(chlorhexidine, tetracycline fiber), using systemic antibiotics, open flap debridement 
(surgical procedures) and other treatments (Pye et al., 2009; Zhao et al., 2009). The 
success rate of these treatments is very poor and usually ends with implant removal 
(Esposito et al., 1998; Pye et al., 2009). Therefore the production of implants with 
antibacterial coatings is suggested to be a successful strategy to prevent the initial 
bacterial colonization. Many surface coatings are used for this purpose. One 
important requirement for these antibacterial coatings is not to impede the 
tissueintegration, but to enhance tissue integration instead (Zhao et al., 2009).  
Coating the surface of the implant with broad spectrum antibiotics is one of the 
attempts to prevent bacterial colonization on the surface of implants. For example, 
antibiotic-hydroxyapatite coatings were used to improve the antibacterial properties 
of the implants (Alt et al., 2006). However, this method fails to incorporate the 
antibiotic into the hydroxyapatite during the formation of the mineral, because of the 
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high temperatures that are usually used to make hydroxyapatite coatings, as in the 
plasma spray method. In addition, the amount of material loaded, and its release 
characteristics, also might be affected due to the physical absorption of the 
antibiotics. For example, in dipping methods 80-90% of antibiotic can be released 
from the calcium phosphate within the first 60 minutes (Radin et al., 1997). 
Furthermore, there are several issues that need to be considered before applying 
these coatings clinically, such as; the long term activity of the antibiotic, whether the 
antibiotics are harmful to human cells or not, and finally ensuring that the dose of 
antibiotics used are effective to inhibit bacterial growth (Zhao et al., 2009). 
      The other types of coatings used to prevent peri-implantitis include antimicrobial 
coatings such as chlorhexidine. Chlorhexidine is a broad spectrum antibacterial 
agent with less risk of drug resistance than antibiotics. It is widely used in dentistry, 
for instance, in mouthwash, and in gelatin to treat periodontal diseases (Heasman et 
al., 2001). Chlorhexidine can be absorbed by the surface of implant and released for 
several days (Kozlovsky et al., 2006). Despite its good antimicrobial efficacy, many 
studies reported that chlorhexidine may cause cell damage (Harris et al., 2006). For 
example, an in vitro study showed that chlorhexidine has toxic effects on human 
fibroblast cells; it suppressed cell divisions, decrease the protein synthesis by the 
cells and other cell activities (Pucher et al., 1992). 
Another approach to prevent the biofilm formation on dental implants is to coat 
the implant surface with inorganic antimicrobial agents such as silver. Silver is well 
known for its antibacterial effects on a broad spectrum of bacteria including antibiotic 
resistant species (Lansdown et al., 2002). The mechanism of the antibacterial action 
of silver is still not fully understood. However, there are several possible mechanisms 
by which silver can kill bacteria. Some studies suggest that the interaction between 
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the silver ions and membrane contents of bacteria might be the cause of its 
antibacterial action (Berger et al., 1976; Jung et al., 2008). Klasen et al. (2000) linked 
antibacterial action of silver to its reaction with thiol group in bacterial respiratory 
enzymes which lead to inhibition of respiration, and consequently mortality of the 
bacteria. In spite of its good antibacterial activity, silver has adverse effects on 
human cells; this depends on many factors such as the speciation chemistry of silver 
in the biological fluids, the distance between the silver and the cells, as well as the 
exposure time. Moreover, the biocompatibility of silver coating will decrease with 
time, inducing changes in the osteoblasts perhaps due to Ag+ toxicity (Cortizo et al., 
2004). The ingestion of colloidal silver solutions by humans may cause argyrosis, 
which is a blue-black discoloration of the skin that may be local or extend to other 
parts of the body, including mucosa and the conjunctiva of the eye (Lansdown et al., 
2002). Likewise, any soluble silver may cause other toxic effects in other organs in 
humans such as, the liver, kidney, and changes in the blood cells (Panyala et al., 
2008).  
The alternative to dissolved silver could be silver nanoparticles (Ag NPs) as they 
have a good antibacterial activity. Like metallic silver the exact mechanism of action 
for Ag NPs is not well known. Shrivastava et al. (2007) showed that Ag NPs 
manifested their antibacterial properties through their effect on the bacterial cell wall 
(penetrating the cell wall), and by modulating cellular signaling by dephosphorylating 
putative key peptide substrates on tyrosine residues. Shrivastava et al. (2007) used 
four different concentrations of AgNPs (5, 10, 25, 35 µg ml-1), all the concentrations 
and especially 25 µg ml-1 were found to be inhibitory to Gram negative bacterial 
growth. In addition, AgNPs may retain their antimicrobial effect for a long period of 
time, possible due to a steady slow release rate of the silver ions from the AgNPs 
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(Cabal et al., 2012). Hence AgNPs would be a good alternative to be used as a 
coating for dental implants. Various methods have been used to prepare AgNPs on 
titanium dioxide such as the sol-gel method, photochemical reduction, and chemical 
reduction in aqueous and non-aqueous solvents (Sharma et al., 2009). Anodization 
has also been used to prepare AgNPs on titanium surfaces (Wan et al., 2007).  
Despite the fact that AgNPs are now being used in the medical field, there is still 
insufficient information about their biological effects on human cells. Hence, further 
studies are needed to clarify their antibacterial properties and cytotoxicity before their 
clinical application (Zhao et al., 2009). Furthermore, there are concerns that AgNPs 
may be toxic to mammalian cells (Foldbjerg et al., 2009; Ahamed et al., 2010). The 
cytotoxicity of AgNPs was found to be concentration-dependent in human cells. it 
has been shown that AgNPs become cytotoxic to human mesenchymal cells at 5 
mg/l, while no toxicity was observed at lower concentration 2.5 mg/l; instead, cell 
growth was induced at the latter concentration (Greulich et al., 2009). Moreover, 
Bosetti et al. (2002) stated that silver-coated material was not toxic to osteoblast-like 
cells compared to stainless steel. In contrast, Albers et al. (2013) found that the 
AgNPs were more toxic to the human osteoblast and osteoclast cells than silver 
microparticles.  
1.3 Biocompatibility of implant materials 
 
The biocompatibility of the implant is essential to make the prosthesis work properly 
in the oral cavity (Chaturvedi et al., 2009). Biocompatibility can be defined as the 
‘‘ability of a material to perform with an appropriate host response in a specific 
application” (Williams, 1987). It largely depends on the mechanical properties of the 
metal such as, corrosion resistance, surface topography, chemical composition of 
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the surface of implants and the type of relation with the host tissues; either it will be 
in direct contact with bone (i.e., osteointegration), or have indirect contact via  fibrous 
tissue (fibrous encapsulation) (Chaturvedi et al., 2009). The materials that are used 
for implants should neither cause adverse reaction nor endanger the life of patients. 
It is well known that titanium and its alloy are cytocompatible, but coating the surface 
of titanium with other material at the micrometer-scale to improve one of the issues 
of implant might adversely affect the cytocompatibility of implants. Silver for example 
may be toxic to human cells as described above (Foldbjerg et al., 2009; Ahamed et 
al., 2010).  
         Corrosion is one of the problems that decreases the biocompatibility of the 
implants and leads to implant failure. It can arise from the degradation of the metal 
surfaces due to electrochemical attack (Anusavice et al., 2003). Corrosion can be 
subcategorised into two types: (i) chemical (dry) corrosion by which metallic and 
non-metallic elements interact and produce chemical compounds, for example by  
oxidation, halogenation or sulphating reactions; and (ii) electrochemical (wet) 
corrosion which mainly depends on the presence of liquids such as water or other 
electrolyte fluids (Chaturvedi et al., 2009). The most common types of corrosion that 
occur in dental implants are fretting corrosion and microbial corrosion (pitting 
corrosion) which are types of wet corrosion (Chaturvedi et al., 2009). Fretting 
corrosion can be defined as process of degradation of the materials that is caused 
by the combined action of a corrosive environment and small movement (fretting 
wear). It mainly occurs between the dental implant and bone during the insertion of 
implant and also due to the cyclic loads of chewing (Gilbert et al., 2009), whereas 
microbial corrosion is caused by the microbial adherence to the surface of the 
titanium. In physiological conditions, bacteria and their metabolites may disturb the 
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passivity of inert metal and lead to production of pitting corrosion on the exposed 
surface of the metal (Chaturvedi et al., 2009).  
   Titanium and its alloy have a good corrosion resistance, which is mainly because 
of the presence of an oxide layer on their surfaces, but this will change with time and 
leads to the breakdown of the outer oxide layer (Tschernitschek et al., 2005). One of 
the other factors that affect the corrosion resistance of titanium is inflammation; this 
make the environment around the implant become acidic and enhances the 
corrosion of the implant (Lassus et al., 1998). Furthermore, modification of the 
surface of titanium to improve their properties may adversely affect the corrosion 
resistance of the titanium, because some modifications resulted in micro cracks, 
hence increasing the corrosion rate. It has been reported that nanomaterials can 
improve the corrosion resistance of implants. For example hydroxyapatite 
nanoparticles can improve the corrosion resistance of implants 50-100 times higher 
than the micrometer thick hydroxyapatite because of their extremely low porosity 
(Zhang et al., 2002). Hydrophobic coatings of titanium dioxide nanoparticles can also 
exhibit an excellent corrosion resistance (Shen et al., 2005). Venkateswarlu et al. 
(2012) reported that silver-substituted hydroxyapatite titania coatings increase the 
corrosion resistance of the titanium by acting as a barrier to the transport of electrons 
and ions between the substrate and the electrolyte. 
1.4 Osseointegration  
 
The success rate of dental implants is closely related to the early osseointegration of 
the implant surface with the bone, and the maintenance of it (Le Guéhennec et al., 
2007; Lavenus et al., 2010; Goyal et al., 2012). Osseointegration can be defined as 
‘a direct, structural and functional connection between organized vital bone and the 
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surface of a titanium implant, capable of bearing the functional load’ (Brånemark et 
al., 1969). Osseointegration occurs in two steps; the first step is known as primary 
stability which is mainly mechanical. The second step of osseointegration is 
biological stability, i.e., cell-implant surface interaction. In the period between these 
two steps there is an observed decrease in the dental implant stability, and because 
of that, implant failure mostly occurs at this time (Lavenus et al., 2010).   
Mechanical stability involves mechanical interlocking between the implant 
surfaces and the bone; it depends mainly on the design of implants and the structure 
of the bone. For example micro rough implant surfaces (1-10 mm) increase the bone 
implant interlocking. Different methods are used to make implants with rough 
surfaces for instance: plasma spraying, grit blasting, acid etching and anodization 
(Le Guéhennec et al., 2007). Each method has its advantage and disadvantage. 
Table 1.1 summarize the advantage and disadvantage of the main methods used to 
increase the roughness of implant surfaces. 
Biological stability on the other hand depends on the interaction between the 
implant surfaces and tissues. After implant placement a series of biological events 
occur, which are: blood and implant interaction, inflammatory response and finally 
initial bone formation (Junker et al., 2009). The interactions that occur between the 
implant surface and blood lead to absorption of many proteins such as, fibronectin 
and vitronectin that play a pivotal role in enhancing cell adhesion (Balasundaram et 
al., 2006).  
   The properties of implant surfaces have an important role in osteointegration. For 
example, the hydrophilicity of an implant may increase the cell attachment to 
implants by their interaction with biological fluids (Steinemann, 1998). It is also 
observed that roughening the surface of implants at the micrometer level will 
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enhance the osteointegration by inhibiting the osteoclastogenesis (Lossdorfer et al., 
2003). However, the rough surface has an adverse effect on implants, because it will 
enhance the bacterial colonization and contribute to subsequent peri-implantitis 
(Romeo et al, 2005). The chemical composition of the implant surface can improve 
the osteointegration, hence different chemicals are used such as, calcium 
phosphate, specifically micrometer thick hydroxyapatite, which is commonly used as 
a coating material because of its high potential to bond to bone (Liljensten et al., 
2003). Many physical and chemical techniques are used to prepare micrometer thick 
hydroxyapatite on the implant surfaces such as sol-gel, plasma spraying, biomimetic 
deposition and electrochemical deposition and others (Koch et al., 2007). The 
hydroxyapatite coatings that are produced by these techniques have some 
disadvantages such as poor adhesion to the titanium surfaces, non-uniform 
thickness and non-stoichiometric composition of the coatings (Hamdi et al., 2000).  
Nanotechnology provides new opportunities for improving the osseointegration 
of titanium implants. For instance, by making the surface of implants mimic the 
surface topography that is produced by the extracellular matrix components of bone. 
Since the extracellular matrix components are at a nanometer scale (10-100 nm), so 
nano-patterend surface implants could be more compatible with human cells (Le 
Guéhennec et al., 2007). The nanocoatings may improve the initial healing around 
the implants by selective attachment of bone cells to implant surfaces (Anselme et 
al., 2002). The proliferation of osteoblasts as well as the long term function of the 
cells was promoted by nanosized grain or fibre of titania, alumina and hydroxyapatite 
(Webster et al., 2000). To improve the osteointegration, electrochemical deposition 
was also used to coat titanium implants with nanomaterials like hydroxyapatite 
nanoparticles (Kim et al., 2009) 
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Table 1.1 Methods used to increase the roughness of titanium implants for better Osseointegration 
Method Description Advantages Disadvantages References  
Acid etching 
 
Immersion of titanium implant in 
strong acid to create micro pits on 
the surface of an implant 
(1)
. 
Increase the roughness of titanium 
implant as such improve the mechanical 
interlocking 
(1)
 
Promote bone formation at bone-implant 
contact through increase the cell 
attachment to the surface because of its 
ability to attach fibrin scaffold 
(3)
. 
The wettability of the surface also play 
role in the bone promotion 
(4)
. 
  Reduce the mechanical properties of 
titanium because it can lead to 
hydrogen embrittlement and create 
micro cracks on the surface 
(2)
. 
 Hydrogen embrittlement may also lead 
to a reduction in the ductility of titanium 
(2)
. 
(Massaro et al., 2002)
(1)
 
(Yokoyama et al., 
2002)
(2)
 
(Buser et al., 2004) 
(3)
 
(Le Guéhennec et al., 
2007) 
(4)
 
Titanium plasma 
spraying 
Producing titanium projections on 
the surface of implant with high 
temperature
 (1)
. 
Increase the tensile strength of the 
implant / bone interface 
(1)
. 
Increase the surface area of implant 
surfaces 
(1)
. 
 
 
Wear particles may have local and 
systemic carcinogenic effect 
(2)
.
 
 
(Buser et al., 1991) 
(1) 
(Martini et al., 2003) 
(2)
 
Anodization Anodizing titanium surface in strong 
acids such as H2SO4, H3PO4, 
HNO3, or HF at high current density 
(200 A/m2) or potential (100 V) 
(1)(2)
.   
 
Strong reinforcement of the bone 
response 
(2)
. 
It is a complex process and affected 
by many parameters such as, 
density, concentration of acid, and 
composition and electrolyte 
temperature 
(3).
 
(Sul et al., 2001) 
(1)
 
(Sul et al., 2002) 
(2)
 
(Le Guéhennec et al., 
2007) 
(3)
 
Grit blasting Blasting the surface of titanium 
implant with different materials by 
projecting the material through a 
nozzle at high velocity with 
compressed air 
(1)
 
Increase the biomechanical fixation of 
titanium implant 
(2)
 
Cannot enhance the biological 
fixation of implants 
(3)
 
(Aparicio et al., 2003) 
(1)
 
(Abron et al., 2001) 
(2)
(Le Guéhennec et al., 
2007) 
(3)
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1.5 Uses of nanomaterials in dental implants 
 
Many in vitro studies have shown that nanostructures are more bioreactive 
(Svanborg et al., 2011), because the nanomaterials have a higher surface area to 
volume ratio, higher number of atoms, and crystal grains at their surfaces; 
consequently this will change the corresponding surface energy for protein 
adsorption (Webster et al., 2001; Liu et al., 2007). It has been reported that 
nanomaterials can increase the interaction between the four proteins (fibronectin, 
vitronectin, laminin, and collagen) which are crucial to osteoblast functioning 
(Christenson et al., 2006). Various nanomaterials (Table 1.2) have been used to 
modify the implant surfaces to improve the clinical outcome (Liu et al., 2007; 
Lavenus et al., 2010). This is by improving the antibacterial and osteointegration 
properties of implants. However the knowledge of the mechanisms by which 
nanomaterials improve the implants are still limited. Nanomaterials that are mainly 
used to coat dental implant include: hydroxyapatite nanoparticles, silver 
nanoparticles and metal oxide nanostructures (See Table 1.2). 
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Table 1.2 Uses of Nanomaterials in dental implants/medical implant 
Nanomaterials 
Purpose of 
experiment 
Experimental design Results References 
Three types of stable 
nanoparticle suspensions 
in water of Calcium 
phosphate have been 
used, 20 nm thickness.  
The coatings are: 
Phosphorous deficient 
Hydroxyapatite (HA) (A), 
needle shaped HA (B) and 
calcium deficient HA (C).  
In vivo evaluation of the 
biological effect of calcium 
phosphate coatings with 
nanostructures on smooth 
implant surfaces.  
Implants were coated with calcium 
phosphate nanoparticles by 
immersion and subsequent heat 
treatment (550
 ◦
C, 5 minutes), the 
surface morphology examined by 
scanning electron microscopy, then 
implants inserted into the tibia of 
rabbits for six weeks in order to 
examine the removal torque testing. 
Uncoated implant was used as 
control. 
Calcium phosphate coatings with 
nanostructures increase the 
biomechanical bonding, they show 
higher removal torque compared to 
control (RTQ = 24.7, 29, 28.2, 32.9 for 
control, A, B, C respectively). Increasing 
the surface area of the dental implants. 
Chemical composition of CaP 
nanocoating has an effect on 
osteointegration. 
(Jimbo et al., 
2012) 
 
Soda-Lime-glass-nAg 
powder with 20% wt of 
silver nanoparticles. (The 
particle size distribution 
of silver nanoparticles 
ranging between 20-90 
nm). 
 
Evaluation the effect of a 
Soda-Lime Glass 
Containing Silver 
Nanoparticles coating on 
Titanium Alloy on the 
streptococcus oralis 
biofilm, and measure the 
release rate of silver from 
the powder.  
  
Titanium substrate coated with 
Soda-Lime-glass-nAg by simple 
sedimentation process (argon 
atmosphere at 980 ◦C   for 1 hour) 
three strains of streptococcus oralis 
grown on coated titanium substrate, 
the surface morphology then 
characterized by scanning electron 
microscopy and profilometer.   
 
The adherence of Streptococcus oralis 
strains ATCC35037, CI-1 and CI-2 to 
titanium coated with soda-lime-glass –
nAg significantly decreased by 99.7, 
99.8, and 99.9% respectively after 24 
hours incubation. 
The release rate of silver was 0.299 mg/ 
L /h, in which determines in different 
time intervals for up to 7 days. 
 
 
 
(Cabal et    
al.,2012) 
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Nanomaterials  Purpose of 
experiment 
Experimental design  Results  References 
Nanoparticles of silver, 
cuprous oxide, cupric 
oxide , zinc oxide, 
silver+cupric oxide 
composite, silver+zinc 
oxide composite  their  
size ranged between 10-
50nm 
Examine the antibacterial 
activity of nanoparticulate 
metals and metal oxides 
against 4 species of gram 
negative bacteria that 
cause peri-implantitis.  
Flame spray pyrolysis was used to 
prepare the nanoparticles. Brain heart 
(BHI) infusion broth used for bacterial 
culture and three species of bacteria 
was used which are: prevotella 
intermedia, prevotella gingivalis, 
fusobacterium nucleatum. Minimum 
inhibitory concentration (MIC) and 
minimum bactericidal concentration 
(MBC) determinations were used to 
test bactericidal and bacteriostatic 
activity of these nanoparticles. 
Nanoparticles were suspended in 
BHI+ hemin, concentrations tested 
were 100, 250, 500, 1000 and 2500 
µg / mL.    
Based on bacteriostatic and bactericidal 
Values (MIC,MBC), the antimicrobial 
activity of six nanoparticles and two 
nanoparticle composites are in 
descending order Ag>Ag+CuO 
composite>Cu2O>CuO> 
Ag+ZnOcomposite>ZnO>TiO2>WO3  
The bactericidal effect was shown to be 
dose- dependent and rapid.  For P. 
gingivalis the effect reached 100% within 
2 hour and within 3 hours for F. 
nucleatum and prevotella intermedia and 
99% within 4 hours for A. 
actinomycetemcomitans. 
 
(Vargas-Reus 
et al., 2012) 
Titanium produced by 
physical vapor deposition 
of titanium on the HCl-
H2SO4. The average size 
of titanium nanonodules, 
ranging from 84nm to 
925nm in linear correlation 
with the deposition time 
nanonodules  
 
Test the hypothesis that 
titanium nanostructure can 
improve titanium-bone 
integration. 
The surfaces of prepared substrate 
were deposited with one of these 
metals (nickel, titanium, chromium, 
silicon, silica) by physical vapor 
deposition. Atomic force microscopy 
(AFM) was used to measure the 
diameter and peak to valley of 
nanonodules. An established 
biomechanical push-in test in the rat 
was used to evaluate the 
osteointegration of nanonodules 
implants. 
 
 
Titanium nanonodules increased the 
surface area of implant by 40% 
compared to acid etched micro structured 
surface when deposition time was 8 min 
20 sec. 
The nanonodules of size 560nm that 
produce when deposition time  was 16 
min 40 sec were selected to test their 
osteointegration by push in test in the rat 
compared to acid etched implant and 
found that the push in value at week 2 for 
nanonodules 3.1 times greater than acid 
etched titanium. 
 
(Ogawa et al., 
2008) 
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Nanomaterials  Purpose of 
experiment 
Experimental design  Results  References 
Poly (lactide-co-
glycolide)/bioactive glass 
Hydroxyapatite (PBGHA) 
nanocomposite coating. 
Nanoparticle amount of 
10, 15, and 20 weight 
percent (wt %) were tested 
to prepare uniform 
nanocomposite coating. 
To prepare and in-vivo and 
in-vitro evaluate a novel 
bioactive, biodegradable, 
antibacterial 
nanocomposite coating for 
dental implant application. 
Solvent casting process was used to 
coat the substrate (commercially pure 
titanium) with nanocomposite. Human 
adipose- derived stem cells (HASC) 
were used to test the attachment and 
viability of the nanocomposite coating. 
The implants were soaked in 
phosphate buffer saline (PBS) in 
order to examine the degradation of 
nanocomposite coating, and 
immersed in stimulated body fluid to 
test the bioactivity. 
 Using 10 wt% nanoparticles (5 wt% HA 
and 5 wt% bioactive glass) can produce 
desirable uniform nanocomposite 
coating on the titanium.  In-vitro study of 
bioactivity showed rapid formation of 
bone-like apatite on prepared 
nanocomposite coatings. After 3 days 
incubation HASC showed a good 
adherence to nanocomposite coatings. 
Nanocomposite coating were degraded 
after 60 days immersion in PBS. 
 
(Mehdikhani et 
al., 2012) 
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1.6 Hypothesis   
 
The main hypothesis being tested in this study is that implants coated with AgNPs and 
hydroxyapatite nanoparticles may  improve the antibacterial properties and 
biocompatibility with osteoblasts respectively. Silver nanoparticles can improve the 
antibacterial activity of titanium implants without causing toxicity to the human bone 
cells. The tested AgNPs can achieve the antibacterial activity either through the 
release of consistent small amount of silver ion or direct contact with the microbes and 
inhibit their growth in suspension and most importantly in biofilm. Furthermore, the 
silver ion release from the tested AgNPs will be lower than the concentration that will 
affect the biocompatibility of the titanium. In addition, hydroxyapatite nanoparticles can 
improve the osteointegration of the implants because it is similar to the chemical 
composition of human bone. Hence it can enhance the absorption of many proteins 
that are important for bone growth on the surface of implants.  
1.7 Aim and objectives 
 
The overall aim of the project was to develop a coating on titanium alloy that can 
prevent biofilm formation by preventing the growth of the early bacterial colonizers. 
Streptococcus sanguinis was used in this study, because it plays an important role in 
biofilm formation on implant surfaces.  
The specific objectives were to:  
(1) Characterize and investigate the antibacterial activity or the minimum inhibitory 
concentration of the nanomaterials (silver, titanium dioxide, and hydroxyapatite) that 
are commonly used for implant coatings.  
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(2) Coat the surface of titanium alloy (Ti6Al4V) with different coatings (silver, titanium 
dioxide, and hydroxyapatite) and characterize them. 
(3) Demonstrate the antibacterial activity of these coatings against Streptococcus 
sanguinis in vitro, and select the coatings that have good antibacterial activity for 
further study. 
(4) Investigate the biocompatibility of the coatings using human osteoblast cells, by 
testing the viability and the cytotoxic response of the cell to the coatings. 
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Chapter 2 
 
The Antibacterial Effects of Different Nanoparticles and Their 
Bulk Material or Metal Salt Equivalents on Streptococcus 
sanguinis 
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2.1.1 Introduction 
 
The development of antibiotic resistant microbes has led to the search  for an 
alternative,effective, antimicrobial agent (Rai et al., 2009). It is established that 
nanotechnology may improved the properties of the materials that are in use in 
medical field (Ciobanu et al., 2012).  Different nanomaterials have been proposed to 
improve the antibacterial activity and/or biocompatibility of medical implants such as, 
nanosilver, titanium dioxide nanoparticles (P25), and hydroxyapatite nanoparticles 
(nHA). Several studies have focused on investigating the antibacterial activity of Ag 
NPs against different microbes (Shrivastava et al., 2007; Sadeghi et al., 2013; Lu et al., 
2013). Nanosilver has good antibacterial activity (Lansdown et al., 2006, Gong et al., 
2007), but many factors might have an effect on the antimicrobial activity of nanosilver 
such as; the type of microbe, the size of the AgNPs, the media used for growing the 
bacteria, and the number of microbes used in the expriments. Sadeghi et al. (2013) 
found that 16 mg/l of nanosilver can inhibit the growth of Streptococcus sanguinis in 
Mueller Hinton broth, whereas 4 mg/l was enough to inhibit the growth of Actinomyces 
viscosus in the same media. The size of the silver nanoparticles also has an effect on 
their antibacterial effect (Hernández-Sierra et al., 2008). The number of the bacterial 
cells applied in the test has also an effect on the ability of nanosilver to inhibit the 
bacterial growth (Sondi et al., 2004).  
          Titanium dioxide nanoparticles have also shown some antibacterial activity 
against Streptococcus mutans at high concentration of 100 mg/l (Besinis et al., 2014). 
Li et al (2008) stated that titanium dioxide nanoparticles showed a good antibacterial 
activity through diverse mechanisms, such as production of reactive oxygen species 
that can damage cell components.  
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2.1.2 Aims and objectives  
 
The aim of this study was to identify the nanomaterial that has a good antibacterial 
activity, in order to use in the dental field such as dental implant. Furthermore, to 
investigate the effect of the physiological saline and NaCl solution on the effectiveness 
of these nanomaterials. The facultative anaerobic bacteria Streptococcus sanguinis 
was used as a clinically relevant microbe. 
The main objectives of the study were to: (i) characterize the nanomaterial dispersions 
(AgNPs, nHA, and P25) and their bulk or salt solutions; (ii) investigate the antibacterial 
activity of the nanomaterial dispersions mentioned above, and to compare them with 
their bulk powder or salts to indicate any particle-size effect on the antibacterial activity 
of these materials (chlorhexidine (clinical disinfectant) was used as a positive control); 
(iii) evaluate the minimum inhibitory concentration assay (MIC) and compare this 
assay with the lactate production assay; (iv) measure the total concentration of silver 
for AgNO3 and AgNPs in physiological saline after bacterial exposure; and (v)  
investigate the dissolution of the nanomaterials in MilliQ water and compare with their 
dissolution in physiological saline. For this reason inductively coupled plasma mass 
spectrometry (ICP-MS) was used,  which is a powerful analytical technique to 
measure the concentration of trace elements (Jenner et al., 1990). 
2.2 Methodology 
2.2.1 Preparation of stock solution / dispersions 
 
Stock solutions and dispersions of 1 g/l were prepared in ultra-pure water for the 
nanomaterials and their bulk powders or metal salts, as appropriate. The materials 
were: (I) silver nanoparticles; (II) (AgNPs) silver nitrate (AgNO3); (III) titanium dioxide 
nanoparticles (P25); (IV) bulk titanium dioxide powder (TiO2); (V) hydroxyapatite 
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nanoparticles (nHA); and (VI) hydroxyapatite microparticles (mHA). The manufacture’s 
information for the materials is listed in Table 2.1. All stocks were sterilized before use. 
AgNO3 solution and AgNPs dispersion were sterilized by autoclaving (121 °C for 15 
min at 15 psi pressure). Gamma radiation (36.42-40.72 KGy for 10 h) was used to 
sterilize remaining stocks, because of concerns that the high temperature of the 
autoclave might affect their reactivity or crystal structure (Besinis et al., 2014). 
Afterwards, all stocks were sonicated (35 kHz frequency, Fisherbrand FB 11010, 
Germany) for 4 h to disperse the materials. Then, serial dilutions were prepared to 
achieve 400, 200, 100, 50, 25, 12.5, 6.25, and 3.125 mg/l). The serial dilutions were 
also sonicated for 4 h before using in the experiments. Two sets of serial dilutions 
were prepared for each material, one in poor nutrient solution (0.85% NaCl) and the 
other in physiological saline. The physiological saline used in this experiment was 
intended to represent the electrolyte composition of blood serum. The physiological 
saline is a modified kerb’s ringer (De Paiva et al., 1993), the component of which are 
shown in Table 2.2. Physiological saline and 0.85% NaCl (without added particles) 
were used as a negative control in the experiment. One % of chlorhexidine was used 
as a positive control, which were then subject to a 50 % dilution series (0.5, 0.25, 
0.125, 0.06, 0.03 v/v), to compare the results with Besinis et al. (2014) study. 
Furthermore, antibacterial activity of the milliQ water was also investigated, two sets of 
dilution series of milliQ were prepared one in physiological saline and the other in 
0.85 % saline (100, 50, 25, 12.5, 6.25, and 3.125 %). The physiological saline was 
filter sterilized (Filter bottle top Steritop vacuum sterile PES membrane 0.22 µm pore 
size 1L 45mm neck size, Fisher scientific,  UK) to prevent potential bacterial 
contamination in the media. Secondary stock dispersions and solutions of 400, 200 
and 100 mg/l were prepared directly from the 1 g/l stock solution for AgNO3 and 
AgNPs in the NaCl solution or physiological saline as appropriate. 
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Table 2.1: Manufacturer’s informations of the materials were used in the experiment 
Material Supplier Manufacture’s information 
Silver nanoparticles  Sigma-Aldrich, Wisconsin, USA, 
lot number 7721KH) 
Purity, 99.5%, <100 nm. Trace elements in 
this batch of dry powder: Al 7.3, B 5.6, Ba 
5.7, Ca 15, Cr 26, Cu 5.5, Fe 229, Mg 1.5, 
Mn 7.9, Na 8.0, Ni 7.0, Sn 15, Ti 4.9 ppm. 
Measured BET surface area, 4.8 m
2
/ g. 
Silver nitrate  Product code s/ 1280/46, Fisher, 
Loughborough, UK 
Purity, 99.9 %, main impurities <10 ppm 
Ca and <20 ppm Na. BET surface area 
below detection limit (<1 m
2
/g) and salt 
contains nitrogen. 
Titanium dioxide nanoparticles  DeGussa P25 particles, from  
Lawrence Industries, Tamworth, 
UK 
Diameter, 21 nm; 
purity, >99%,approximately 25% rutile and 
75% anatase,  maximum impurity of 1% 
Si), specific surface area 50 ± 15 m2 /g. 
Measured BET surface area, 46.7 m
2
 /g. 
Bulk TiO2 powder   Acros, New Jersey, USA Titanium (IV) oxide, purity of 98.0–100.5% 
TiO2. Measured BET surface area, 8.7 
m
2
/g 
 
Hydroxyapatite microparticles  Fluidinova, Rua Eng. Frederico 
Ulrich 2650, 4470-605 Maia, 
Portugal 
Highly pure forms of hydroxyapatite, with 
no additives, measured BET surface area 
greater than 120 m
2
/g.   
 
Hydroxyapatite nanoparticles  Fluidinova, Rua Eng. Frederico 
Ulrich 2650, 4470-605 Maia, 
Portugal 
Highly pure nanocrystalline hydroxyapatite, 
supplied as 15 % wt. paste, with no other 
additives. Measured BET surface area, 
greater than  80 m
2
/g 
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Table 2.2: Physiological saline components (modified Kerb’s ringer) 
Chemicals Concentration (mM) 
Sodium chloride (NaCl) 118  mM 
Potassium chloride (KCl) 3 mM 
Magnesium sulfate pentahydrate (MgSO4.5H20) 1 mM 
Calcium chloride (CaCl2) 2 mM 
Bicarbonate buffer (NaHCO3) 25 mM 
Potassium dihydrogen phosphate (KH2PO4) 1.2 mM 
Glucose 10 mM 
 
2.2.2 Characterization of the nanomaterials 
 
In order to investigate the particle size distribution in the media that were used in 
the experiment, the nanomaterials and their equivalent bulk or metal salts were 
characterized using nanoparticle tracking analysis (NTA, using a Nanosight LM 10, 
Nanosight, Salisbury, UK, laser output set at 30 mW at 640 nm). NTA detects the 
particles moving under Brownian motion, and relates the particle movement to particle 
size using Stokes-Einstein Eq.I  which is as follow (Filipe et al., 2010): 
 
where kB is the Boltzmann constant and (x, y)2 is the mean squared speed of a 
particle at a temperature T, in a medium of viscosity η, with a hydrodynamic radius of 
rh (Filipe et al., 2010). Briefly, the initial 1 g/l stocks in milliQ water were diluted to 100 
mg/l in physiological saline as described previously in (section 2.2.1). Then the 
samples were continuously sonicated until they were analysed (n = 3).   
 
(x, y)2 =  
2KBT 
3rh 𝜋ŋ 
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2.2.1 Experimental design and preparation of microplates 
 
The experimental design involved exposing Streptococcus sanguinis to serial dilutions 
of different nanomaterials and their bulk powder/salt. S. sanguinis was used as a 
clinically-relevant microbe. S. sanguinis NCTC 10904 was originally isolated from 
dental plaque. The vials as supplied from Health Protection Agency Culture 
Collections were stored at - 80°C in liquid nitrogen until required. Bacterial cells were 
firstly grown for 36 h on plates of Columbia blood agar (Oxoid), with 5% sheep blood, 
and then incubated for 24 h in 15 ml of brain heart infusion broth (BHI, product code: 
OXCM1135B, Fisher scientific, Loughborough, UK) supplemented with 2% sucrose 
(BHI) incubated at 37 °C under  5 % CO2 and 95% air. The bacterial culture that used 
in this experiment was in exponential stage (Appendix A). The cell suspension was 
adjusted to a final concentration of 107 CFU/ml, determined by optical density at 595 
nm. After preparing the serial dilutions of the nanomaterials and their bulk, as well as 
the negative and positive control ( section 2.2.2), 250 µl from each serial dilutions and 
25 µl of bacterial suspension were added to each well of a 96 well microplate (flat-
bottom sterile polystyrene microplates, dis-210-070j, Fisher Scientific, UK). The 
experiment was carried out in 6 replicates and 96 well microplates was used as the 
unit of replication. Additional set of plates were prepared (n = 3 plates), to determine 
the turbidity of the nanomaterials and their bulk. These plates were identical to those 
in the main experiment, except for adding the broth without added bacteria (time-
matched turbidity measurement of the nanomaterials). Then all plates were incubated 
for 24 h in 37°C and 5% CO2 and 95% air incubator. 
For the purpose of bacterial growth measurement, MIC and lactate production assays 
were performed. MIC can be defined as the lowest concentration of the material that 
can inhibit the growth of bacteria (Andrews et al., 2001). This assay has been routinely 
 27 
 
used by the microbiologists to measure bacterial growth (Besinis et al., 2014). The 
turbidity was measured at an absorbance of 595 nm using a VersaMax plate reader 
(VersaMax microplate reader with SoftMax Pro 4.0 software, Molecular Devices, 
Sunnyvale, CA). Furthermore, the silver ion release from silver nanoparticles and 
silver nitrate in physiological saline was measured. After 24 h exposure, 200 µl from 
each dilutions of AgNPs and AgNO3 was transferred to V-shaped bottom 96 well 
plates and  centrifuged for 10 min. then 150 ul of the supernatant was diluted in 2% 
nitric acid and the silver was measured by ICP-MS. 
2.2.3 Lactate production assay 
 
The amount of the lactate produced by S. sanguinuis was measured using the lactate 
production assay, as an indicator of the presence of metabolically active bacterial cells 
(Besinis et al., 2014). After 24 h incubation of the plates, 100 μl from each well were 
transferred to V-shaped bottom 96-well plates (code: 3896, corning, UK). Then the 96-
well plate was centrifuged for 20 minutes at 2000 rpm (2040 Rotors microplate 
centrifuge, Centurion Scientific Ltd, Ford, UK). Ten μl of the supernatant from each 
well was carefully transferred to flat bottom 96-well plates and mixed with 211 μl of a 
lactate assay reagent. The lactate assay reagent consists of 200 μl of 
glycine/hydrazine buffer, 10 μl of 40 mM nicotinamide adenine dinucleotide (NAD+, 
Melford Laboratories Ltd, Suffolk, UK) and 1 μl of 1000 units/ml lactate 
dehydrogenase (LDH, Sigma-Aldrich Ltd, Dorset, UK). The glycine/hydrazine buffer 
was prepared by dissolving 0.4 M hydrazine and 0.5 M glycine in Milli-Q water and the 
pH adjusted to 9 using a few drops of 6 M potassium hydroxide. Samples were 
incubated for 2 h at 37 °C incubator, and then absorbances were read with the 
VersaMax plate reader at 340 nm. Absorbances were converted to molar 
concentration using a calibration curve of lactic acid standards in triplicate (0, 0.125, 
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0.25, 0.5, 1.0, 2.0, 4.0, 8.0, and 16 mM). The standards were prepared by adding 480 
µl of 30 % lactic acid to 100 ml of MilliQ water to get 16 mM, and then a 50 % serial 
dilution was made to get 8, 6, 4, 2, 1, 0.5, 0.25, 0.125 mM (Appendix B). 
2.2.4 Dialysis experiment 
 
This experiment was performed to investigate whether the materials used in the above 
experiment will dissolve in physiological conditions. This was determined by 
measuring the apparent total dissolved metal concentrations that could pass through 
the dialysis bags into the external media. The dialysis method is based on Handy et al., 
(1989) with modifications for nanomaterials. Briefly, the experiment consists of 
preparation of 100 mg/l of AgNPs, AgNO3, P25, nHA and mHA solutions, the initial 1 
g/l stock dispersions and solutions were used to prepare the 100 mg/l stock solution in 
physiological saline and milliQ water as described in section 2.2.2. All the tested 
solutions were sonicated for 4 h before adding to the dialysis bags. All glassware of 
identical shape and size was acid washed in 5 % nitric acid for 24 h and then rinsed 
three times with milliQ water. The dialysis bags (18 cm long x 25 mm wide, dialysis 
tubing product code: D9777, cellulose membrane with a molecular weight cut off at 
12,000 Da, Sigma-Aldrich, St. Louis, USA) were filled with 8 ml of the appropriate 
stock dispersion, solution, or a control (control groups were milliQ water or 
physiological saline with no added particles). The ends of the bags were secured by 
making knots in the bottom and putting medi-clips at the top. The beakers were filled 
with 492 ml of either milliQ water or physiological saline. Then, the bags were 
immediately placed in the beakers (they were held by thread to maintain the dialysis 
bags in the middle of the beaker). The beakers were gently stirred on a multipoint 
magnetic stirrer (RO 15P power, IKa- Werke GmbH & Co. KG, Staufen, Germany) for 
24 h at room temperature. Samples (4.5 ml) were taken from the beakers for metal 
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analysis and pH measurements at 0, 30 min, 1 h, 2 h, 3 h, 4 h, 6 h, 8 h, and 24 h. Five 
hundred µl of the samples was used to measure the pH and the remaining (4 ml) were 
analysed by ICP-MS for total metal concentrations. Furthermore, the temperature of 
the media in the beakers was measured at each time point. The remaining contents of 
the dialysis bag were also collected at the end of the experiment for metal analysis. 
2.2.5 Statistics 
 
All data were presented as mean ± S.E.M, and were analysed using STATGRAPHICS 
Centurion XVI.I. The differences between the tested samples and the control; and 
within each group (dilution effect) were evaluated using one-way ANOVA or Kruskal-
Wallis. The All statistical analysis used a 95 % confidence limit, curve fitting for 
dialysis experiment were done using Sigma Plot 12.0 (Systat Software, Inc.).  
2.3 Results 
 
2.3.1 Particle size distribution 
 
The particle size distribution of the nanomaterials and their bulk or salt equivalents in 
physiological saline was measured using NTA (Figure 2.1). The mean value of 
aggregate size in control physiological saline (mean ± S.E.M, n = 3) was 147 ± 12 nm. 
Dispersion of 100 mg/l AgNPs in physiological saline resulted in an aggregate size 128 
± 17 nm. While average aggregate sizes of 100 mg/l AgNO3 was 145 ± 13 nm. The 
average aggregate size for bulk TiO2 and the P25 material was 130 ± 10 nm and 150 ± 
18 nm respectively, and 171 ± 15.64 nm, 99 ± 14.1 nm for mHA and nHA respectively. 
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Figure 2.1 Particle size distribution in physiological saline, A) Physiological saline (control), B) silver nitrate, C) 
silver nanoparticles, D) titanium dioxide (bulk), E) titanium dioxide nanoparticles, F) hydroxyapatite 
microparticles and G) hydroxyapatite nanoparticles (mean ± S.E.M, n=3). 
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2.3.2 Minimum inhibitory concentration (MIC) assay 
 
The turbidity of the inoculated solutions after 24 h incubation was measured at 595 nm. 
Figure 2.2 shows the turbidty of the nanomaterial and their bulk in physiological saline. 
The  reference microplates (the test solutions with no added bacteria) were used to 
correct the data by subtracting the turbidity caused by the particles alone from the 
inoculated solution (Figure 2.2). This resulted in negative values for most of the 
solutions at the high concentrations of these materials, but did adequately correct for 
particle turbidity at lower concentrations in each dilution series. According to the 
turbidity measurements, most of the test substances had a concentration-dependent 
effect on the growth of S. sanguinius. All the dilutions of AgNO3 are significantly lower 
than the control physiological saline, as the turbidity of inoculated physiological saline 
(mean ± S.E.M) was  0.401 ± 0.012, and the highest concentration of AgNO3 (400 
mg/l) was showed a negative value (- 0.168 ± 0.004), whereas the other dilutions of 
AgNO3 were showed some growth but significantly lower than the control 
(physiological saline, Figure 2.2). AgNPs also showed a siginficant difference with 
physiological saline, as 400 mg/l showed a negative values. Whereas 200 and 100 
mg/l of AgNPs showed 33.6 % and 37 % growth inhibition compared to control. Other 
dilutions of the AgNPs showed higher absorbance values compared to the control. 
The high concentrations of TiO2 nanoparticles and bulk  also showed negative values 
and the more diluted solutions showed a concentration-effect on bacterial growth. 
Likewise, mHA and nHA also had a concentration-effect on the bacterial growth. 
Chlorhexidine caused full growth inhibition at concentrations of 1, 0.5, and 0.25 %. 
While the lower concentrations of chlorhexidine (0.125, 0.06, and 0.03%) showed no 
significant difference with the control. The turbidity of milliQ water (without added 
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physiological saline) was significantly lower than control (physiological saline), as the 
bacterial grwoth in milliQ water was lower by 78 % compared to physiological saline.  
Figure 2.3 shows the results of turbidity of the nanomaterials and their bulk after 
24 h exposure in 0.85 % NaCl. The high concentrations of AgNO3 (400, 200, and 100 
mg/l) showed high absorbance values compared to the control (0.85 % NaCl alone), 
even after subtracting the natural turbidity of the particles (Figure 2.3), whereas the 
turbidity of the more diluted solutions was siginificantly lower than the control. The 
AgNPs series of dilutions showed growth inhibition down to a concentration of 25 mg/l, 
whereas the more diluted AgNPs showed no growth inhibition. P25 and TiO2 showed 
negative values at high concentrations, whereas the low concetrations of both 
materials were not significantly different from control.  
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Figure 2.2 the effect of nanomaterials on the growth of S. sanguinuis in physiological saline over 24 h in the minimum inhibitory 
concentration test (MIC). The absorbance values were read at 595 nm. B) Absorbance values after subtracting the natural turbidity of the 
particles. (+) shows a significant difference from the physiological saline control (Kruskal-Wallis, p<0.05). Within each test solution, different 
letters indicate a statistically significant dilution effect (Kruskal-Wallis, p<0.001). The absence of letters indicates no statistical differences 
between any of the dilutions within the series. 
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Figure 2.3 the effect of nanomaterials on S. sanguinuis in 0.85% NaCl over 24 h in the minimum inhibitory concentration test (MIC). The 
absorbance values read at 595 nm. B) Absorbance values after subtracting the natural turbidity of the particles. (+) shows the significant 
difference from the control (Kruskal- Wallis, p< 0.001). Within each test solution, different letters indicate a statistically dilution effect 
(Kruskal-Wallis, p< 0.001). The absence of letters indicates no statistical differences between any of the dilutions within the series. 
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2.3.3 Lactate production 
 
The lactate produced by S. sanguinis was measured after 24 h exposure to different 
nanomaterials and their bulk/metal salts in both 0.85% NaCl and physiological saline 
(Figure 2.4). In physiological saline (Figure 2.4 A), there was no lactate production in 
any of the dilutions of AgNO3. Whereas all dilutions of AgNPs showed full lactate 
production like the control, except 400 mg/l of AgNPs which showed a 99.5 % 
decrease in lactate production compared to the control. The remaining materials (P25, 
TiO2, nHA, and mHA) showed no significant difference with the control; high level of 
lactate was measured in all dilutions. Chlorhexidine showed a concentration-effect on 
the lactate production. No lactate was detected in 1 % (v/v) chlorhixidine, whereas the 
lactate levels in 0.5 % and 0.25 % (v/v) chlorhixidine were lower than the control by 
99.5 % and 91.1 %  respectively. MilliQ water had a concentration-effect on lactate 
production; lactate production in 100% milliQ water was 80.3 % lower than the control, 
whereas further diluted samples showed a negligible decrease in lactate production 
compared to physiological saline.  
Overall, S. sanguinis produced lower concentration of lactate in 0.85 % NaCl 
compared to physiological saline (Figure 2.4 B); the maximum lactate production was 
4.355 mM in 0.85 % NaCl whereas in physiological saline was 20.363 mM. Figure 3 B 
shows that the lactate levels in all AgNO3 dilutions were lower than the control by 
approximately 90 %. Among the nanoparticles, AgNPs showed antibacterial activity 
against S. sanguinis in the 400, 200, 100, and 50 mg/l dilutions; the lactate production 
was 91 % lower than the control and lactate levels remained statistically lower than the 
control in the further dilutions of AgNPs.  The lactate production in the P25 and bulk 
TiO2 dilutions were statistically lower than the 0.85 % NaCl control, but still were at 
millimolar levels (> 3.5 mM).  
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Intrestingly, the high concentrations of mHA (400, 200, 100, and 50 mg/l) showed 
higher lactate levels compared to the control (0.85 % NaCl); the lactate level was (in 
mM) 7.052 ± 0.17, 6.180 ± 0.068, 5.17 ± 0.11, 4.936 ± 0.31 for 400, 200, 100, and 50 
mg/l of mHA, respectively. While lower concentrations of mHA (25, 12.5, 6.25, and 
3.125 mg/l) showed no significant difference with the control. nHA showed no 
significant difference with the control in all dilutions. Chlorhexidine showed a 
concentration-dependent antibacterial effect against S. sanguinis; the lactate levels in 
1%, 0.5 %, and 0.25 % (v/v) dilutions were upto 90 % lower than the control. The 
lactate production in 0.125 % and 0.06 % (v/v) chlorhixidine was lower than the control 
by 65 %  and 24 % respectively. While the 0.03 % dilution showed no significant 
difference compared to the control. MilliQ water did not show a negative effect on the 
lactate production compared to the control. In contrast, 100 % milliQ water (with no 
added 0.85 % NaCl) showed higher lactate production compared to control. 
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Figure 2.4 the concentration of lactate (mean ± S.E.M in mM) produced by S. sanguinuis exposed 
to different nanomaterials and their bulk after 24 h. A) Nanomaterials and their bulk in physiological 
saline. B) Nanomaterials and their bulk in 0.85% NaCl. “+” shows significant difference from the 
control group (physiological saline and 0.85% NaCl) (Kruskal-Wallis, p<0.001), within the test 
solution, different letters indicate statistically significant dilution effect (Kruskal-Wallis, p<0.001) 
between the dilution series. 
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2.3.4 Measuring the concentration of dissolved silver 
 
After 24 h incubation, the concentration of the dissolved silver in all serial dilutions of  
AgNPs and AgNO3 in physiological saline was measured using ICP-MS (Table 2.3). It 
is apparent that the dissolution of silver was very low for all the dilutions of AgNO3 and 
AgNPs. In general the silver concentration in AgNO3 serial dilutions was higher 
compared to the AgNPs. Interestingly, the silver concentration in the nominal 400 mg/l 
AgNPs was lower than the more diluted dispersions of AgNPs (nominal concentrations, 
200, 100, 50, and 25 mg/l). 
 
Table 2.3: The concentration (mg/l) of the dissolved silver in physiological saline at 
24h in the MIC assay after centrifugation 
Nominal  Concentration mg/l       AgNO3          AgNPs 
400 0.469 ± 0.02 ab          0.104 ± 0.00 abc 
200 0.437 ± 0.03 ac 0.161 ± 0.01 a 
100 0.507 ± 0.01 ab 0.160 ± 0.00 a 
50 
25 
12.5 
6.25 
3.125 
0.498 ± 0.02 b 
0.387 ± 0.03 cd 
0.343 ± 0.02  d 
0.288 ± 0.02  e 
0.027 ± 0.00  f 
0.131 ± 0.01 ab 
0.117 ± 0.01 ab 
0.078 ± 0.01 bc 
0.034 ± 0.00 cd 
0.011 ± 0.00 d 
Data are presented as (mean ± S.E.M), data sharing different letters within columns are 
statistically different (Kruskal-Walis, p< 0.03) 
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2.3.5 Dialysis experiment 
 
The results of the dialysis experiment showed that the total dissolved silver from 
AgNPs in both milliQ water and physiological saline was lower compared to AgNO3. 
Figure 2.5A shows the cumulative amount of silver released for AgNPs and AgNO3 in 
milliQ water. Silver concentration remained in few micrograms per liter for AgNPs over 
24 h. In contrast, AgNO3 completely dissolved in milliQ water, as the dissolution of 
silver from AgNO3 in milliQ water reached 0.5 mg (mean of triplicate, absolute amount 
released) after 8 h. While in physiological saline, the dissolution of AgNO3 was lower 
compared to its dissolution in milliQ water; the maximum rate of appearance of 
cumulative total silver in physiological saline was 0.1 mg over 24 h. The dissolution of 
AgNPs in physiological saline was only 0.017 mg/l over 24 h (Figure 2.5 B). Figure 2.6 
shows the cumulative amount of Ti released for  the P25 material, there was no 
detectable titanium dissolution in milliQ water. While in physiological saline, a few 
micrograms of Ti rapidly appeared in the external media. The cumulative amount of Ti 
released over 24 h was 25 µg. 
To investigate the dissolution of nHA and mHA, the concentration of of calcium 
and phosphorus in the external media was measured during dialysis. Figures 2.7A and 
B shows the cumulative amount of calcium and phosphourus released over 24 h. An 
increase in the concentration of calcium and phosphorus was observed in milliQ water 
for both nHA and mHA. In physiological saline, ICP-MS measurements includes the 
concentration of calcium and phosphorus in physiological saline and  nHA and mHA 
(Figure 2.7 C and D).  
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Figure 2.5 The cumulative appearance of total Ag metal (in mg) through dialysis tubing 
into the external medium of beakers for dialysis bags containing 100 mg/l AgNO3 and 
AgNPs using either A)  milliQ water or B) physiological saline. The data points are 
mean values derived from triplicate measurements (n = 3 beakers per treatment). 
Curves are fitted to the mean data points shown using a rectangular hyperbole 
function (one site, ligand binding to saturation) in Sigma Plot version 12.  • refers to 
silver nanoparticles (AgNPs), and ◦ refers to silver nitrate (AgNO3). 
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y = 0.0002+0.0006*x/(1.070+x) 
r
2
 = 0.9248 
y = 0.002+0.0225*x/ (3.4129+x) 
 r
2
 = 0.9865 
Figure 2.6 The cumulative appearance of total Ti metal (in mg) through dialysis 
tubing into the external medium of beakers for dialysis bags containing 100 mg/l P25 
using either milliQ water or physiological saline. The data points are mean values 
derived from triplicate measurements (n = 3 beakers per treatment). Curves are fitted 
to the data points shown using a rectangular hyperbole function (one site, ligand 
binding to saturation) in Sigma Plot version 12.5. • refers to the dissolution of P25 in 
physiological saline, and ◦ refers to the dissolution of P25 in milliQ water. 
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Figure 2.7 The cumulative appearance (in mg) of total calcium and phosphorus through dialysis tubing into the external medium of 
beakers for dialysis bags containing 100 mg/l nHA and mHA using either milliQ water or physiological saline. The data points are mean 
values derived from triplicate measurements (n = 3 beakers per treatment). Curves are fitted to the data points shown using Hyperbola, 
Single Rectangular I, 3 Parameter in Sigma Plot version 12.5. A) nHA in milliQ. B) mHA in milliQ. C) nHA in physiological saline. D) mHA 
in physiological saline. 
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2.4  Discussion 
 
This study reports the antibacterial activity of different nanomaterial dispersions and 
their bulk powder or metal salt against the clinically-relevant microbe, S. sanguinis. 
Two different solutions (0.85 % NaCl-BHI broth + 2 % sucrose medium, and 
physiological saline-BHI broth + 2 % sucrose) were used to test the antibacterial 
effects of the nanomaterials. The bacterial growth was determined by two different 
assays; the MIC and lactate production assays. The main findings were that silver 
nitrate was the most effective antibacterial material against S. sanguinis, and among 
the tested nanomaterials, only AgNPs showed antibacterial activity against the 
bacteria. The MIC of silver nanoparticles is 50 mg/l in 0.85 % NaCl and 400 mg/l in 
physiological saline. Furthermore, the growth of the bacteria in milliQ water (with no 
added NaCl) was higher compared to its growth in 0.85 % NaCl. In terms of 
antibacterial assays, lactate production assay could be a good alternative to routine 
measurements of growth inhibition with the  MIC method, because the latter relies on 
turbidity measurements which can be problematic for the nanomaterials.  
2.4.1 Characterization of the nanomaterials and their equivalent bulk powder or 
salt solutions  
 
The need to characterize the nanomaterials prior to any in vitro study is highly 
important, especially for those nanoparticles where their toxicity depends mainly on 
the particle size (Murdock et al., 2008). The nanoparticles and their bulk or metal 
salts were characterized in the physiological saline using NTA (Figure 2.4). The main 
finding of this study was that the physiological saline (with no added particles) 
showed a hydrodynamic diameter of aggregates (147 ± 12 nm). It seems possible 
that this high background noise is due to the presence of salt crystals in 
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physiological saline. Hence, it was difficult to get reliable values for the particles 
distribution in physiological saline, particularly for AgNO3 and AgNPs (Figure 2.4B 
and C). This is mainly because of rapid precipitation of the silver in a solution 
containing NaCl. It is well known that silver has a high ability to bind to the halide 
groups and will produce insoluble particles of silver chloride. The results of dialysis 
experiment also support this idea, as the dissolution of both silver nitrate and AgNPs 
were drastically decreased in physiological saline (Figure 5.2B). This is probably 
mainly due to AgCl formation. This finding is in accordance with a study done by 
Loza et al. (2014), who found that the dissolution of AgNPs is very low in the 
presence of NaCl in the biological solutions.  
The titanium dioxide nanoparticles and microparticles were also characterized 
using NTA (Figure 2.4D and E); they did show a negligible difference in the particle 
size distribution compared to its distribution in milliQ water as reports in Besinis et al. 
(2014). This means that the nano form has aggregated to make aggregates of a 
similar size to that of the bulk material. In contrast, dialysis experiment showed that 
the dissolution of titanium dioxide nanoparticles was higher in physiological saline 
compared to milliQ water. Hence, this should be considered when titanium dioxide 
will be used in the medical field; as the titanium dioxide can accumulate in the 
tissues (Fabian et al., 2008).  
Furthermore, the results of dialysis experiment showed that hydroxyapatite 
nanoparticles and microparticles almost completely dissolved in water (Figure 2.7A 
and B). Hydroxyapatite, upon dissolution, will release calcium and phosphorus which 
are the main component of hydroxyapatite. This finding is in agreement with Clark et 
al. (1955) who showed that hydroxyapatite has ability to dissolve in the water. It was 
difficult to investigate the dissolution of hydroxyapatite in the physiological saline, 
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because this media contains a high concentration of calcium and phosphorus. 
However, cumulative increase was noticed in the beaker over time for both 
hydroxyapatite nanoparticles and microparticles (Figure 2.7C and D), which can be 
related to their dissolution. This finding seems to be consistent with the research 
done by Tsui et al. (1998) who found that hydroxyapatite can dissolve in ringer 
solution, but at a low rate. Nevertheless, in term of comparing the change in the 
dissolution of hydroxyapatite in water and in biological fluid, it is difficult to use these 
results.  
2.4.2 MIC assay 
 
The MIC assay was used to determine the antibacterial effect of the nanomaterials 
and their equivalent bulk or metal salts. Overall, the results showed that the growth 
of bacteria was higher in physiological saline than in 0.85 % NaCl media. This is 
because physiological saline is a more nutrient-rich media for the bacterial growth 
than a simple salt solution. Moreover, the results showed that most of the tested 
materials had a concentration-dependent antibacterial effect in both media (0.85 % 
NaCl and physiological saline, Figure 2.2 and 2.3). Previous research done by 
Besinis et al. (2014), using bulk TiO2, showed antibacterial effect upto 12.5 mg/l. 
This is because different microbe was used for the study. The  MIC of nHA and mHA 
was 200 mg/l in 0.85 % NaCl, whereas the antibacterial effect of nHA was upto 50 
mg/l in physiological saline. Hydroxyapatite nanoparticles and microparticles did not 
show any antibacterial effects. Overall, these  data must be interpreted with caution 
because the MIC assay has some limitations for testing nanoparticles, especially at 
high concentrations (> 12.5 mg/l, Besinis et al., 2014).  The MIC assay depends on 
measuring the absorbance of the samples, and the nanoparticles  used in this study 
added some turbidity to the media. Hence, the natural turbidity of the particles may 
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potentially mask any absorbance caused by the bacteria. The protocol of Besinis et 
al. (2014) was followed to improve the validity of the turbidity measurements in the 
MIC assay, by subtracting the natural turbidity of the particles. This correction led to 
negative values for most of the materials at high concentrations in both media 
(physiological saline and 0.85 % NaCl, Figure 2.2 and 2.3). This could be due the 
effect of the bacteria on aggregation of the particles (Otsuka et al., 2003). The 
aggregated particles allow the light of spectrophotometry to pass through the sample 
faster, so the absorbance values  become lower. Hence the absorbance values of 
the particles alone was higher than the absorbance value of particles and bacteria.  
Interestingly, the turbidity of AgNO3 (nominal concentrations, 400, 200, and 100 
mg/l) in the 0.85% NaCl was significantly higher than the control (0.85 % NaCl alone). 
This finding was unexpected and there are two explanations for this observation, 
either (i) the silver was not bioavailable to inhibit the bacterial growth, or (ii) the high 
absorbance values is due to rapid precipitation of silver as silver chloride, in the 
presence of high concentration of silver in 0.85 % NaCl solution. The latter seems 
more likely, as the AgNO3 showed high antibacterial activity even at lower 
concentration (50 down to 3.125 mg/l of AgNO3). While in physiological saline, 
AgNO3 showed high antibacterial activity against S. sanguinis in all concentrations, 
and did not show high absorbance values in nominal concentrations 400, 200, and 
100 mg/l. This finding is somewhat surprising, an explanation for this could be the 
presence of other chemicals in physiological saline that impede the precipitation of 
silver as AgCl formation. Another possible explanation could be due to the difference 
in chloride concentration in these two solution. The concentration of chloride in 
physiological saline was 123 mM and 145.5 mM in 0.85 % NaCl solution; the higher 
concentration of chloride in the latter might have an effect on the silver precipitation. 
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Another observation was that the antibacterial activity of AgNPs in 0.85 % NaCl 
media was better than its activity in physiological saline. AgNPs showed bacterial 
growth inhibition down to 25 mg/l in 0.85 % NaCl. This finding accords with the 
earlier observations by Besinis et al, (2014), which showed that AgNPs also had 
antibacterial effect against Streptococcus mutans down to 25 mg/l in 0.85 % NaCl. 
AgNPs have less antibacterial activity in physiological saline compared to the 0.85 % 
NaCl, this could be due to the fact that AgNPs lose its bioavailability in more complex 
media. For example, Stebounova et al. (2011) stated that the bioavailability of the 
AgNPs will decrease in a solution with high ionic strength, due to their settling in 
such media. 
 
2.4.3 Lactate production assay 
 
The lactate assay was used to investigate the antibacterial activity of different 
nanomaterials. This assay relies on the metabolic activity of the bacteria; apparently 
it is more sensitive than the MIC assay (Besinis et al., 2014). A high lactate 
concentration in the media would indicate metabolic lactate production from live cells. 
Consequently, an increase in lactate concentration might infer a higher percentage 
of surviving bacteria. The results indicated that the bacteria was growing better in 
physiological saline compared to their growth in 0.85 % saline (Figure 2.3A and B). 
That was not unexpected, because it is well known that bacteria can not grow well in 
high concentration of sodium chloride alone. The high concentration of NaCl 
solutions are traditionally used for food preservation (Doyle et al., 2010). Silver 
nitrate showed a higher antibacterial activity against S. sanguinis in both 
physiological saline and NaCl solution compared to the most common disinfectant in 
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use in dentistry (chlorheixidine), this results are consistent with those found by 
Besinis et al. (2014). Moreover, the antibacterial activity of AgNO3 in physiological 
saline was higher compared to its activity in 0.85 % NaCl (Figure 2.3). It is supposed 
that the antibacterial activity of silver will differ, depending on the composition of the 
media that is used for bacterial growth. This could be due to the higher concentration 
of chloride in 0.85% NaCl compared to chloride concentration in physiological saline 
as described previously. This may result in the rapid precipitation of AgNO3 and slow 
its action against the bacteria. Hence, the bacteria were produce some lactate before 
their death, but this lactate subsequently remained in the media.  
Contrary to AgNO3, the AgNPs showed higher antibacterial effect on S. sanguinis in 
0.85% NaCl compared to its effect in physiological saline (Figure 2.3). This probably 
mainly due to the effect of high electrolyte content of physiological saline on the 
AgNPs, by which led to its aggregation and loss of the bioavailability (Lok et al., 
2007).  Furthermore, the presence of glucose in the media could also slow down the 
dissolution of AgNPs and inhibits their action against bacteria consequently (Loza et 
al., 2014).  
The TiO2 nanoparticles and bulk did not show any antibacterial activity against S. 
sanguinis in physiological saline, and showed a negligible effect in the 0.85% NaCl. 
This may be because NaCl solution in broth is not a complete media for the bacteria 
to grow as mentioned earlier, hence the bacteria will become more sensitive to 
unfavorable condition and their metabolic activity will decrease. No growth inhibition 
was noticed in all hydroxyapatite nanoparticles/ microparticles solution. Interestingly, 
the high concentrations of hydroxyapatite microparticles increase the growth of 
bacteria in NaCl, since the hydroxyapatite  contributes to  the  favorable conditions 
for the bacterial growth (Rameshbabu et al., 2007). Another possible explanation 
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could be due to the fact that the dissolution of the hydroxyapatite will lead to calcium 
and phosphorus release in the media; this resulted in a nutreint-rich media that can 
increase the growth of the bacteria.  
2.5 Conclusion 
 
The purpose of this study was to characterize different nanomaterials and investigate 
their antibacterial activity against S. sanguinis. The following conclusion can be 
drawn from the present study: 
1- Only Ag NPs had antibacterial activity among the tested nanomaterials. Moreover, 
antibacterial effect of Ag NPs in 0.85 % NaCl was better than in physiological saline. 
2- AgNO3 was showed antibacterial activity against the tested microbe in all 
concentration and in both tested media.  
3- Another significant finding to emerge from this study is that, the lactate production 
was more reliable than MIC assay for investigating the antibacterial effects of 
nanoparticles.  
4- Finally, the dissolution of both AgNO3 and AgNPs was very low in the 
physiological saline compared to milliQ water, this is mainly due to the presence of 
chloride.  
Taken together, these findings suggests an important role for the composition of the 
media in the antibacterial activity of silver nanoparticles and salts.   
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Chapter 3  
Investigating the antibacterial activity of different coatings 
on titanium discs against Streptococcus sanguinis
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3.1 Introduction 
 
Peri-implantitis due to biofilm formation is one of the leading causes of medical and 
dental implants failure (Norowski et al., 2009). Several studies have focused on 
improving the surface of the implants for better anti-biofilm properties (Huang et al., 
2010; Vogel et al., 2014; and Mei et al., 2014). To date, various methods have been 
developed to provide coatings with novel properties for the implants that can also 
prevent biofilm formation on their surfaces. Recently, a number of different 
researchers have sought to develop a multi-layered coating for the implant 
composed of silver and a bioactive material such as hydroxyapatite (Ciobanu et al., 
2012; Akiyama et al., 2013). Moreover, it was proposed that electrically prepared 
silver coatings could show a broad spectrum antibacterial activity (Scales et al., 
1984).  
The stability of the coating is one of the essential criteria that is difficult to obtain, 
because most of the biomaterials will act differently when they come in contact with 
the body fluid (Williams, 1987). For example, metals such as silver can release free 
ions in the biological fluid which might circulate in the blood. The exact mechanism 
by which silver ion circulate in blood is unknown, but might be related to strong 
binding of silver ions with proteins (Walker et al., 2012). Hence, it is important to 
ensure a controlled or negligible ion release from the implant surface over the long 
term. Furthermore, detachment of the coating from the surface of implant might also 
compromise the mechanical stability of the implant; leading to its failure (Yang et al., 
2003). 
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 The aim of this study was to prepare a stable coating for the titanium that has a 
good anti-bacterial property; using simple inexpensive techniques. The main 
objectives were to: (i) prepare and characterize different coatings on titanium 
surfaces, (ii) investigate the antibacterial activity of different coatings against one of 
the early colonizers of the biomaterial surfaces, S. sanguinis. Qualitative and 
quantitative methods were used for this purpose, and (iii) evaluate the stability or the 
degradation of the coatings in the physiological conditions. 
3.2 Methodology 
3.2.1 Preparation of titanium discs 
 
Titanium discs, 15 mm in diameter and 1 to 1.5 mm thickness, were cut by a laser 
from medical grade 5 titanium alloy (Ti6Al4V). To standardize surface 
characteristics, the titanium discs has been polished by sand paper (#800-1200) 
using a rotary instrument (Grinder-Polisher, Buehler, UK Ltd, Coventry, England) for 
10 minutes. The final polishing was performed using 0.1 µm diamond solution 
(Diamond solution, Kemet International Ltd, Parkwood Trading Estate, Maidstone, 
Kent ME15 9NJ UK). Then, the discs were cleaned with 20 g/l of NaOH + Na2CO3 
solution in an ultrasonic bath (Metason 129T, Struers). To remove the oxide layer on 
the surface of the discs, further cleaning was carried out by immersing the discs in 
5% HCl solution for 3-5 minutes.  
3.2.2 Coating techniques  
 
Three techniques were used to coat the titanium discs: (i) solution deposition and 
heating for hydroxyapatite micro and nanoparticles, (ii) electroplating to coat the 
discs with silver, and (iii) anodization to coat the discs with titanium dioxide. 
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Ultimately, nine types of titanium discs were prepared which were: uncoated Ti alloy 
used as a control group, silver plated (Ag), anodized (TiO2), hydroxyapatite 
nanoparticles coated (nHA), hydroxyapatite microparticles coated (mHA), silver 
plated then coated with hydroxyapatite nanoparticles (Ag + nHA), silver plated then 
coated with hydroxyapatite microparticles (Ag + mHA), anodized and then coated 
with hydroxyapatite nanoparticles (TiO2 + nHA), anodized and then coated with 
hydroxyapatite microparticles (TiO2 + mHA). 
3.2.3. Electroplating 
 
Electroplating is a process of coating a metal with a thin layer of another metal by 
putting it in a chemical solution (the electrolyte) through which an electric current 
flows. The  discs were cleaned (section 3.2.2), then the silver solution (electrolyte) 
was heated to 40°C which increase the adhesion of silver to the titanium. The silver 
solution was made of 0.2 M Ag, 0.4M succinimide and 0.5 M KOH with pH 8.5.  
Discs were hung on silver wire which was connected to the cathode (negative side) 
of the DC power and another silver wire was connected to the anode (positive side), 
and both sides (cathode and anode) were dipped in an electrolyte and the voltage 
was adjusted to 1 V and left for 3 minutes. Finally the discs were washed with 
distilled water and dried with a hair dryer. Figure 3.1 illustrates the silver plating 
method.  
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Figure 3.1 Silver-plating technique 
 
3.2.4 Anodization to coat the alloy surface with titanium dioxide 
 
This technique was used to produce a dense, compact and thin oxide layer on the 
titanium surface. First of all, discs were ultrasonically cleaned as described 
previously, then the disc was held on platinum wire and connected to the anode; the 
copper plate was connected to the cathode. Then both sides were dipped in the 
electrolyte; 5 g/l sodium acetate (NaAc) was used as an electrolyte solution. DC 
power was used to apply the anodization voltage. The voltage was adjusted to 30 V 
for 5 minutes in order to get a thin layer of titanium oxide. Finally the discs were 
removed and washed with distilled water and dried with a hair dryer. 
3.2.5 Deposition and heating technique 
 
This technique was used to coat the titanium discs with hydroxyapatite nanoparticles 
or microparticles. This technique includes deposition of hydroxyapatite nanoparticles 
or microparticles solutions on the titanium discs, then heating the coated discs upto 
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500 °C. Heating the hydroxyapatite coating has an important role in increasing the 
bonding strength between the hydroxyapatite and the titanium surface (Kim et al., 
2004). Briefly, 15 % wt/v of hydroxyapatite nanoparticles and microparticles solutions 
were used for this technique. The hydroxyapatite nanoparticles solution was 
purchased from Fluidinova (Rua Eng. Frederico Ulrich 2650, 4470-605 Maia, 
Portugal); whereas 15 % wt/v hydroxyapatite microparticles solution was prepared 
by adding 15 g of hydroxyapatite microparticles powder (Fluidinova, Rua Eng. 
Frederico Ulrich 2650, 4470-605 Maia, Portugal) to 100 ml of water. Firstly, discs 
were sterilized with 70 % ethanol and were put in 24 well microplates (flat-bottom 
sterile, tissue culture treated polystyrene microplate, code: Greiner 662160, Bio-One 
Ltd., UK), Then 20 µl of hydroxyapatite (nanoparticles/microparticles) solution was 
added to the top of the discs and distributed evenly by pipette. The samples were left 
at room temperature to dry for 2 days. Afterwards the discs were put in a porcelain 
dish and put in the furnace (Carbolite, ELF 11/14, UK). The setting of the furnace 
was adjusted by which the temperature increased gradually (10 °C each min) until it 
reached 500 °C. Then the furnace was kept at this temperature for 10 min. Finally, 
the samples were left to cool down to room temperature. The reason for adjusting 
the temperature to 500 °C was to prevent the damage of the silver plated discs, as 
this temperature is lower than the melting point of silver. The time of heating the 
samples was adjusted to only 10 min at 500 °C to preserve the crystallinity of the 
hydroxyapatite. 
Prior to using the technique above, a pilot study was carried out to investigate 
the effect of heating on the adhesion of hydroxyapatite microparticles and 
nanoparticles coatings to titanium discs. The concentration of the calcium and 
phosphorus released into the NaCl solution was measured, as it is an indicator of 
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coating degradation. The approach to the experiment was that hydroxyapatite (micro 
and nanoparticles) solution was applied on titanium surface as described above. 
After this the discs were divided into two groups (n = 3), the first group was heated 
up to 500 °C and the second group were not. Then the discs of each group were 
placed in a glass bottle contained 70 ml of 0.85 % NaCl. Then the glass bottles were 
placed in a sonic bath up to 10 minutes. Samples (0.7 ml) were taken from the glass 
bottles in different times (0, 1, 2, 3, 4, 5, and 10 minutes). Then 0.7 ml of 2% nitric 
acid was added to each sample and measured by ICP-MS for metal concentrations 
(Table 3.1). Based on the results of this pilot study, heated discs showed less 
hydroxyapatite degradation (i.e. better adhesion of the coating). Hence, heating 
technique was used to coat the discs with hydroxyapatite. Furthermore, the 
Hydroxyapatite nanoparticles showed better adhesion to the titanium discs 
compared to hydroxyapatite microparticles. 
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 Table 3.1 Total phosphorus and calcium concentration in µg/l released from hydroxyapatite coated 
discs after sonication up to 10 min to check degradation. 
The total concentration of the phosphorus and calcium (in µg/l) that released from the hydroxyapatite 
coatings, data are presented as mean ± S.E.M (n = 3), Different letters are statistically different from each 
other within the column (one way ANOVA, p<0.05). * means statistic significant difference between the 
heated and non-heated nHA or mHA in each time point (one way ANOVA, p< 0.05). # indicates a statistic 
significant difference between the nHA and mHA samples at each time point for heated and non-heated 
groups (one way ANOVA, p<0.05). 
 
 
Time/
min 
   Total phosphorus  (µg/l) 
Non heated nHA Heated nHA Non heated mHA Heated mHA 
0 1.1 ± 1.4 a 0.07 ± 0.02 a 0.2 ± 0.03 *a 0.00 ± 0.01 *a 
1 
2.3 ± 1.4 ab 0.5 ± 0.2   a 4.0 ± 0.6 * b 1.4 ± 1.4 *bc 
2 
5.08 ± 0.6 bc 2.29 ± 1.7 a 5.22 ± 0.08 *c 1.54 ± 0.2 *bc 
3 
5.50 ± 0.4 *bc 1.86 ± 0.3 *b 5.05 ± 0.5 *c 1.8± 3.3 *bc 
4 
7.397 ± 0.5 *#cd 1.26 ± 0.15 *ab 5.437 ± 0.3 *#c 1.28 ± 0.5 *ab 
5 
6.84 ± 0.6 *#c 2.64 ± 0.2 *#ab 5.28 ± 0.2 #c 3.05 ± 1.06 #d 
10 
10.40 ± 1.8 d 4.59 ± 1.1 b 5.66 ± 0.2 *c 3.2 ± 0.6 *c 
 
Time/
min 
 Total calcium (µg/l)   
Non heated nHA Heated nHA Non heated mHA Heated mHA 
0 
4.7 ± 6.6 a 0.4 ± 0.08 a 0.6 ± 0.1 a 0.2 ± 0.02 a 
1 
5.8  ± 3.6 #a 1.9 ± 0.4 a 9.6 ± 1.4 #b 3.9 ± 3.5 b 
2 
12.66 ± 1.7#b 6.08 ± 4.1 ab 12.5 ± 0.1 *#c 4.25 ± 0.4 *bc 
3 
13.71 ± 0.8 *b 5.17 ± 0.8 *c 12.3 ± 1.3 *c 5.0 ± 1.7 *bc 
4 
17.583 ± 1.5 *#b 4.361 ± 0.5 *abc 12.87 ± 1 *#c 4.5 ± 1.85 *ab 
5 
16.57 ± 1.5 *#b 7.38 ± 0.7 *#bc 12.99 ±  0.5 #c 7.92 ± 2.4 #c 
10 
24.68 ± 3.9 c 11.74 ± 2.4 c 13.62 ± 0.6 *c 8.7 ± 1.4 *d 
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3.2.6 Characterization of the titanium discs 
3.2.6.1 Surface roughness 
 
The surface roughness, Ra, was quantified by using an Olympus LEXT Confocal 
Microscope OLS 3000, with a total magnification of 50× and an optical zoom of 1×. 
Ra is an arithmetical mean of surface roughness of every measurement within the 
total measured distance (Lou et al., 1998). Surface roughness was measured at 
three different locations in each of 3 replicates from each treatment. The topography 
was also investigated by taking 3D images using an Olympus LEXT Confocal 
Microscope OLS 3000. 
3.2.6.2 Investigating the surface topography and chemical composition of 
titanium discs 
  
Scanning electron microscopy (SEM, JEOL / JSM-7001F, Oxford instruments INCA 
X-ray analysis system) was also used to qualitatively investigate the surface 
topography of prepared titanium discs. At least one replicate from each type were 
coated with chromium cobalt and examined by SEM. The detective energy was 15 
Kev at a working distance of 10 mm. In addition, Qualitative element analysis using 
Energy Dispersive Spectroscopy (EDS) was performed (spot size: 10 µm; 
accelerating voltage: 15 kV; working distance 10 mm), data and spectra analysis 
were achieved using Aztec 2.2 software. 
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3.2.7 Antibacterial properties of the different coated discs 
 
3.2.7.1 Experimental design 
 
The experiment involved exposing S. sanguinis in 24-well microplates (flat-bottom 
sterile, tissue culture treated polystyrene microplate, code: Greiner 662160, Bio-One 
Ltd., UK) for 24 h to different coated titanium discs. Titanium discs were placed in 
24-well microplates using sterile forceps, then sterile physiological saline and 
bacterial suspension were added to each well in a 1:10 ratio (S. sanguinis culture 
was prepared as described in chapter 2 section 2.2.1). Then the 24-well microplates 
were incubated at 37 °C under 5% CO2 and 95 % air for 24 h. The 24-well 
microplates was used as the unit of replication in the experiment (n = 6 
plates/treatment); one of each coated discs above was added to each plate including 
two control groups (uncoated control disc and blank well with no disc as a 
reference). At the end of the exposure time (24 h), the external media were 
assessed for bacterial growth measuring the turbidity, the proportion of lactate 
production, and cell viability using a live/dead kit. The integrity of the different 
coatings was also tested by measuring the metal concentration in the external media 
using ICP-MS. Furthermore the biofilm formation on the discs also investigated 
(section 3.2.7.2). 
3.2.7.2 Assessing the adherence of the bacteria to the discs 
 
To investigate the the adherence of bacteria to the coated discs comparing to the 
control uncoated disc, two methods have been used, scanning electron microscopy 
(section 3.2.7.3) and the protocol used by Besinis et al. (2014) with some 
modification. In brief, the titanium discs were carefully removed from the 24-well 
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microplates by sterile forceps. Each disc was washed three times with sterile saline 
(0.85 % NaCl) to remove the unattached cells. Then each disc was placed in a 
separate sterile glass bottle contained 2 ml of sterile 0.85 % NaCl and sonicated in 
the ultrasonic bath (35 kHz frequency, Fisherbrand FB 11010, Germany) for 60 
seconds to remove the attached cells. Then the discs were removed and the 
solutions vortexed for a few seconds to homogenize it. Then, 500 µl of the media 
from the sonicated discs was aliquoted into 5 ml of BHI + 2 % sucrose and incubated 
for 16 h at 37 °C under 5% CO2 and 95 % air. The media from the blank well with no 
disc from the experiment was mixed well with a pipette, and then centrifuged for 10 
min at 2000 rpm (2040 Rotors microplate centrifuge, Centurion Scientific Ltd, Ford, 
UK). Then the media were removed and the pellet containing the microbes was 
washed with saline twice and re-suspended in 2 ml of 0.85 % saline. Then 0.5 ml of 
the resulting solution was diluted in 5 ml of BHI + 2 % sucrose broth and incubated 
for 16 h. The bacterial growth was assessed using lactate production, the live/dead 
kit, and turbidity assays. 
3.2.7.3 Bacterial adhesion and electron microscopy  
 
The bacterial growth on the different coated discs was also investigated  qualitatively 
using SEM. Briefly; titanium discs were exposed to S. sanguinis for 24 h exactly as 
described previously (n = 2). At the end of the exposure time the discs were washed 
with 0.85 % NaCl to remove the detached bacteria and were subsequently fixed with 
2.5 % glutaraldehyde solution for 2 h. The specimens were dehydrated in a series of 
ethanol steps (50, 75, 95, 100 %) for 30 minutes in each concentration, then the 
discs were immersed in 50/50 ethanol / hexamethyldisilazine (HDMS) for 30 min, the 
specimens were then dipped in 100 % HDMS for 20 min. Finally, the discs were left 
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in the fume cupboard to dry. The resultant specimens were then coated with 
chromium in a sputter coater and visualised for remaining bacterial cells with SEM. 
The detective energy was 20 Kev and working distance was 10 mm. 
3.2.7.4 Bacterial growth measurement 
 
The bacterial growth of both suspended (external media) and the attached cells 
(media from the sonicated discs) were assessed by measuring the turbidity, by 
transferring 275 µl of the external media (after 24 h) and sonicated media (after 16 h) 
to 96-well plates (flat-bottom sterile polystyrene microplates, dis-210-070j, Fisher 
Scientific, UK). The turbidity was measured at 595 nm absorbance using a 
VersaMax plate reader (VersaMax microplate reader with SoftMax Pro 4.0 software, 
Molecular Devices, Sunnyvale, CA).  
3.2.7.5 Lactate production assay 
 
The amount of the lactate that was produced by S. sanguinis was measured using 
the lactate production assay. For the suspended bacteria, after 24 h incubation, 100 
μl from each well were transferred to V-shaped bottom 96-well plates (code: 3896, 
corning, UK). Then the 96-well plate was centrifuged for 20 minutes at 2000 rpm. 
Then the amount of lactate in the supernatant was measured as described in chapter 
2 (section 2.2.3). Similar to suspended bacteria, the same technique was used to 
measure lactate production in the supernatant of attached bacteria after 16 h. 
3.2.7.6 Assessing cell viability (live/dead assay) 
 
The viability of suspended cell after 24 h exposure, as well as the attached cells after 
16 h incubation, was examined using L7012 Live/Dead® Backlight™ Kit (Invitrogen 
Ltd, Paisley, UK). The manufacturer’s protocol with an optimized emission 
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wavelength was used as described by Besinis et al (2014). The kit consists of two 
stains, SYTO 9 which is a green fluorescent DNA stain for all kinds of cells, and 
propidium iodide, a red fluorescent stains for cells with a compromised membrane. 
The ratio of 1:1 of these two stains was mixed into sterile milliQ water to bring the 
final concentration of the stains (red and green fluorescent stain) to 0.6 %. 
Afterwards, 100 µl of the sample was transferred into a 96-well plate (flat-bottom 
sterile polystyrene Microplates, dis-210-070j, Fisher Scientific, UK) and mixed with 
the same volume of the staining solution. The 96-well plates were then incubated for 
15 min at room temperature. The 96-well plates were covered with tin foil during the 
incubation time, because the stains are sensitive to light. A Cytofluor II, fluorescence 
plate reader (perspective Biosystems, Framingham, MA) was used to assess the 
samples. Two different emissions were used to assess the samples, 530 nm for 
SYTO 9 dye and 645 nm for the propidium iodide. The excitation wavelength was 
480 nm for both dyes and the gain was 70.  
3.2.7.7 Calibration of live dead assay 
 
In order to convert the fluorescence data of the live/dead assay to equivalent live 
cells percentage values (Appendix C), the protocol of Besinis et al, (2014) was 
followed with some modification. Two sets of calibration curves were prepared, one 
for the 24 h exposure (external media) and the other for 16 h exposure (media of the 
sonicated discs). This is because of the difference in the type of the media used to 
grow the attached and suspended bacteria. In brief, S. sanguinis culture was 
prepared as described in chapter 2 (section 2.2.1). For the 24 h calibration curve, the 
resuspension of the cell pellet and washing was performed in physiological saline-
BHI. While for the 16 h calibration the resuspension and washing of cell pellet was 
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performed in 0.85 % NaCl-BHI. Calibration used 100% live (no treatment) and 100 % 
dead (in 70% formaldehyde for 3 h at room temperature) cells. Then the calibration 
curve was plotted as reported in Besinis et al. (2014). A typical calibration for 24 h 
gave a linear response (e.g., r2 = 0.998; y = 0.1311x+6.6267), and for the 16 h gave 
a linear response (e.g., r2 = 0.994; y = 0.1402x + 5.9573). 
3.2.7.8 Re-investigating the antibacterial activity of anodized groups and silver 
plated 
 
The above experiment was repeated again, due to concerns about the results of 
anodized groups (TiO2, TiO2+nHA, and TiO2+mHA discs); the solution that was used 
for anodization was likely contaminated with some silver. Hence new anodized discs 
were prepared in uncontaminated solution and the experiment repeated exactly as 
described above, except for the concentration of calcium in physiological saline had 
also been corrected, since an incorrect concentration was used in the previous 
experiment; 1.55 mM of CaCl2 was used in the first run instead of 2 mM. Moreover, 
Ag discs were also used in this experiment, to check whether using a silver plate 
source rather than silver wire in the silver plating process had an effect on 
antibacterial activity of the Ag discs. Similar to the first run, Ti discs were used as 
control groups in this experiment. 
3.2.9 Statistical analysis 
 
All data were presented as mean ± S.E.M, and were analysed using 
STATGRAPHICS Centurion XVI.I. The differences between the tested samples and 
the control were evaluated using one-way ANOVA or Kruskal-Wallis. All statistical 
analysis used a 95 % confidence limit. 
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3.3 Result 
3.3.1 Characterization of the titanium discs 
 
The titanium discs were successfully polished and coated with silver, titanium dioxide 
and hydroxyapatite. There was a difference in roughness between the different 
coatings. Table 2 illustrates that Ag or TiO2 discs showed no significant difference 
with the Ti (control) discs in roughness (one way ANOVA, p>0.05). In contrast the 
discs that were coated with hydroxyapatite (microparticles or nanoparticles) from all 
groups were significantly rougher than control disc (one way ANOVA, p<0.01); 3D 
images (Figure 9) confirmed this. In addition, there were some cracks on those discs 
coated with hydroxyapatite nanoparticles (Figure 3.2D, E and F). While Ag, TiO2, 
and Ti showed surfaces without cracking (Figure 3.2A, B, and C).  
EDS analysis (Figure 3.3A) showed an elemental composition of 80.5 % titanium, 
11.4 % vanadium, and 3.8 % aluminium for the uncoated discs. The discrepancy 
from manufacturer’s data (Al 5.5-6.75 %, V 3.5-4.5 %) is due to the non-uniform 
distribution of elements in the material. While for the silver plated discs showed 97 % 
of silver, traces of other elements were also detected from the surface (Figure 10B). 
On the other hand, the surface of the anodized titanium discs consisted of 11.7 % 
oxygen, 79.5 % titanium, and traces of aluminium and vanadium (Figure 10C). For 
the discs that coated with hydroxyapatite nanoparticles and microparticles (Figure 
3.4 and 3.5), calcium and phosphorus can be easily detected on the surface of all 
the discs that coated with hydroxyapatite. 
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Table 3.2: surface roughness measurements of different coated titanium discs 
Surface                     Roughness (Ra) 
Polished uncoated (control) 
0.212 ± 0.02 a 
Hydroxyapatite microparticles (mHA) coated disc 1.149 ± 0.20 bc 
Hydroxyapatite nanoparticles (nHA) coated disc 2.501 ± 0.25 d 
Anodized (TiO2) 0.217 ± 0.02 a 
Anodized and coated with nHA 
0.755 ± 0.009 e 
Anodized and coated with mHA 
1.183 ± 0.12 c 
Silver plated 
0.267 ± 0.06 a 
Silver plated and coated with nHA 0.783 ± 0.01 be 
Silver plated and coated with mHA 
0.948 ± 0.12 bce 
* data are expressed as (Mean ± S.E.M, in µm), different letters are statistically  different from 
each other (Kruskal-Wallis, p = 0.003). 
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Figure 3.2 3D images obtained from a confocal 
microscopy (Olympus LEXT Confocal Microscope 
OLS 3000) A,B,C show the uncoated, silver plated, 
and anodized discs respectively before coating 
with hydroxyapatite there is no any irregularities. 
D, E, F show the three groups after coating with 
hydroxyapatite nanoparticles, cracks can be 
observed on their surfaces. G, H, I show the three 
groups after coating with hydroxyapatite 
microparticles, they showed rough surfaces.  
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Figure 3.3 Scanning electron micrographs (SEM) and EDS analysis of titanium discs a) 
uncoated titanium alloy disc, 80 % of the surface is titanium and 11 % vanadium; b) silver plated 
disc, 97 % of the surface content is silver; c) anodized discs show 14 % oxygen and 80 % 
titanium. The image in the left is the SEM graph and the right side indicate the EDS analysis. 
The image in the left is the SEM graph and the right side indicate the EDS analysis,scale bar 10 
µm  
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Figure 3.4 Scanning electron micrographs (SEM) and EDS analysis of hydroxyapatite 
microparticles a) uncoated titanium coated with hydroxyapatite microparticles, b) silver plated 
coated with hydroxyapatite microparticles; b) anodized coated with hydroxyapatite microparticles. 
The image in the left is the SEM graph and the right side indicate the EDS analysis, scale bar 10 
µm. 
a 
b 
c 
 69 
 
a 
b 
c 
 
Figure 3.5 Scanning electron micrographs (SEM) and EDS analysis of hydroxyapatite 
nanoparticles.  a) Polished titanium coated with hydroxyapatite nanoparticles, b) silver plated 
coated with hydroxyapatite nanoparticles; b) anodized coated with hydroxyapatite nanoparticles. 
The image in the left is the SEM graph and the right side indicate the EDS analysis, scale bar 10 
µm. 
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3.3.2 Investigation of the bacterial growth suspended in the external media  
 
The growth inhibition of S. sanguinis was investigated by measuring the turbidity of 
the media at 595 nm using a Versa Max plate reader. Statistical analysis showed a 
significant difference between the treatment groups (Kruskal-Wallis, p<0.005); Figure 
3.6A shows that there was growth inhibition on all silver plated and anodized groups 
in the external media. The media of nHA, and mHA discs showed negligible 
decreases in bacterial growth compared to the control groups.  
The amount of lactate produced by the bacteria was measured (Figure 3.6C), as 
an indicator of metabolism from living cells. There was no lactate in the external 
media of all anodized and silver plated groups. In contrast, there was lactate in the 
external media of nHA and mHA discs, but it was still significantly lower than the 
control groups (blank and uncoated disc, Kruskal Wallis, p<0.005).  
The proportion of viable cells in the external media was also measured using the 
live/dead assay (Figure 3.6E). The data were normalized to the control (uncoated 
titanium discs); assuming that the bacterial growth was 100 % in the control. Similar 
to the lactate and turbidity results, there was a significant decrease in cell viability in 
the external media of all anodized and silver plated discs; as the bacterial viability 
was lower than the control (uncoated Ti disc) by approximately 90 %. While the cell 
viability in the external media of the nHA and mHA discs was 20 % lower than the 
control (uncoated Ti disc).  
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3.3.3 investigating of the bacterial adherence to the titanium discs 
 
The turbidity of media obtained from sonicated discs was measured as it indicates 
the growth of bacteria on the discs. Similar to the external media there was a 
significant difference in the turbidity between the groups (Kruskal-Wallis, p<0.001). 
There was a growth inhibition on all silver plated and anodized groups (Figure 3.6B). 
While, there was bacterial growth on the uncoated discs, interestingly the bacterial 
growth on the nHA and mHA groups was higher than the uncoated discs.  
The results of the lactate production assay also showed a significant difference 
between the different titanium discs (Kruskal-Wallis, p<0.005). There was a 
significant reduction in lactate production on all silver plated and anodized groups 
compared to the control (uncoated Ti discs, Figure 3.6D). In contrast, nHA and mHA 
discs showed high lactate production compared to the control (uncoated Ti discs). 
Figure 3.6F shows the results of the live/dead assay for attached bacteria; the 
data was normalized to control group (uncoated Ti discs) as for the external media. 
The viability of the bacterial cells was significantly reduced on all anodized and silver 
plated discs compared to control Ti discs (Kruskal-Walis, p< 0.05). while the viability 
of the bacteria on nHA and mHA discs was higher than control Ti discs. 
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Figure 3.6 Growth inhibition of S. sanguinuis A) the turbidity of external media, B) the turbidity of attached 
bacteria to different titanium coated discs, C) lactate production in external media, D) lactate production of 
attached bacteria to different titanium coated discs.(Kruskal-Wallis, p<0.001), E) proportion of live 
bacterial cells  in external media after normalization with control discs (Ti), F)  proportion of live bacterial 
cells  attached to the discs after normalization with control discs (Ti). Different letters indicate significant 
difference between the groups. 
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3.3.4 Assessing the bacterial attachment to titanium discs by SEM 
 
The bacterial growth on the coated titanium discs was qualitatively analysed using 
SEM. Control uncoated discs showed a full growth of bacteria on the surfaces; S. 
sanguinis did not show any sign of stress and grew in multiple layers (Figure 3.7A). 
Likewise, nHA and mHA discs and all anodized groups were showed full bacterial 
growth (Figure 3.7B, C, D, E, and F). In contrast, the silver plated group (Figure 3.8G, 
H, and I) did not display any bacterial growth on their surfaces. Surprisingly, one of 
the Ag plated replicate (Figure 3.8B) showed bacterial growth; there were fewer 
numbers of bacterial cells compared to the control disc ( Figure 3.7A) and S. 
sanguinis culture of filter paper (Figure 3.8 A) with a large amount of extracellular 
matrix, possibly mucopolysaccharide.  
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H 
Figure 3.7. Scanning electron micrographs of different coated titanium discs exposed to S. sanguinuis for 24 h, A) Ti disc, B) nHA disc, C) mHA disc, D) 
TiO2 disc, E) TiO2+nHA disc, F) TiO2+mHA disc, All the discs showed full bacterial growth G) Ag disc, H) Ag+nHA disc, I) Ag+mHA disc, showed no 
growth on their surfaces. Scale bar, 10 µm 
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Figure 3.8  Scanning electron micrograph of A) S. sanguinis culture, B) silver plated 
disc after exposing to S. sanguinuis. A huge amount of extracellular matrix covered 
the surface of silver plated disc. Scale bar= 10 µm, magnification 2000x. 
 
3.3.4 Investigating the stability of the coatings 
 
In order to check the stability of the silver coatings on the titanium discs, the 
concentration of the silver was measured in both the external and sonicated media. 
In the external media (Table 3.3), silver release from silver plated discs coated with 
hydroxyapatite (Ag+nHA and Ag+mHA) is higher than the release of silver from silver 
A 
B 
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plated disc (Ag without HA). The concentration of silver was 0.163 ± 0.013 and 0.342 
± 0.013, 0.32 ± 0.011 mg/l for Ag, Ag+nHA and Ag+mHA respectively (mean ± 
S.E.M., n = 6). The external media of anodized groups was contained silver, which 
was more than the detection limit (< 0.04 mg/l). It was 0.075 ± 0.01, 0.056 ± 0.009, 
and 0.052 ± 0.01 mg/l for TiO2, TiO2+nHA, and TiO2+mHA respectively (mean ± 
S.E.M).    Silver concentrations in the media of sonicated discs were also measured. 
Overall, higher silver concentration observed in the media of sonicated discs 
compared to the external media, as the total silver concentration was 0.704 ± 0.039, 
0.825 ± 0.084, and 0.632 ± 0.036 mg/l for Ag, Ag+nHA and Ag+mHA discs 
respectively (mean ± S.E.M). Furthermore, the anodized group also showed high 
silver concentration in the media after sonication (Table 3.3).  
The concentration of calcium and phosphorus in both media were also measured as 
an indicator of hydroxyapatite coating degradation. In external media, there was a 
significant difference between the groups in calcium concentration (Kruskal Wallis, 
p<0.005). The concentration of calcium for silver plated and anodized groups was 
lower compared to the control groups (Table 3.3). In the sonicated media, it was 
observed that the concentration of calcium was high for all the groups that were 
coated with hydroxyapatite compared to those discs that were not coated with 
hydroxyapatite (Table 3.3). Phosphorus concentration in the external media showed 
no significant difference for all groups. In contrast, the media obtained from 
sonicated discs showed high concentrations of phosphorus compared to control 
(Kruskal-Wallis, p > 0.05). 
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External media: the concentration of the coating materials in the external media after 24 h., data expressed as means ± S.E.M (n = 6 for each treatment). Different 
letters are statistically different from each other within the column (Kruskal- Wallis test, p< 0.05. Sonicated media: the concentration of the coating materials in the media 
after sonication for 1 min. data expressed as means ± S.E.M (n = 6 for each treatment). Different letters are statistically different from each other within the column 
(Kruskal- Wallis test, p< 0.05). 
Table 3.3 Total Ag, Ti, P, and Ca concentrations (mg/l) released from the discs to the external media after 24 h, and to the media of sonicated discs after 1 min. 
 Treatment    Materials  in mg/l     
Ag  Ti  P  Ca  
External media blank 0.00  ± 0.00   a  0.01 ±0.00  a  112.43 ±1.61  a 56.00 ± 0.80 ab 
 Ti 0.00  ± 0.00   a   0.07 ± 0.01  b  101.9 ± 9.77  ab   56.10 ± 4.15 ab 
 Ti+nHA 0.01 ± 0.00  a  0.02 ± 0.00  a  96.14 ± 16.0  ab 73.28 ± 20.10 b 
 Ti+mHA 0.01 ± 0.00  a  0.02 ± 0.00  a  109.9 ± 7.49  ab 78.28 ± 13.30 b 
 TiO2 0.07 ± 0.01  b  0.02 ± 0.00  a  97.24 ± 1.94  ab 34.27 ± 0.61 ac 
 TiO2+nHA 0.05 ± 0.00  b  0.01 ± 0.00  a  109.7 ± 6.26  ab 46.95 ± 18.64 ac 
 TiO2+mHA 0.05 ± 0.01  b  0.01 ± 0.00  a  100.8 ± 4.22  ab 28.08 ± 2.69 c 
 Ag 0.16 ± 0.01  c  0.02 ± 0.00  a  93.7 ± 12.87  ab 32.09 ± 6.14 ac 
 Ag+nHA 0.34 ± 0.01  d  0.01 ± 0.00  a  89.95 ± 1.45  b 17.51 ± 0.65 c 
 Ag+mHA 0.32 ± 0.01  d  0.01 ± 0.00  a  94.84 ±1.53  ab 27.05 ± 2.91 ac 
Sonicated media Ti 0.04 ± 0.01  ab  0.01 ± 0.01 a  3.47 ± 1.91     a 2.36 ± 1.38  ab 
 Ti+nHA 0.03 ±  0.01  ab  0.31 ± 0.09 b  39.46 ± 14.12 b 20.4±6.70    cd  
 Ti+mHA 0.01 ±  0.04  a   0.28 ± 0.09 b  42.10 ± 11.44 b 21.2 ± 5.05  cd 
 TiO2 0.14 ±  0.01  b  0.00 ± 0.02 a  0.59 ± 0.08     a 0.21 ± 0.02   a 
 TiO2+nHA 0.13 ± 0.03  ab  0.04 ± 0.01 a  5.75 ± 0.42     a 3.62 ± 0.22   abc 
 TiO2+mHA 0.15 ± 0.05   b  0.22 ± 0.09 b  25.26 ± 10.34 b 14.04 ± 5.26 cd 
 Ag 0.70 ±   0.03   c  -0.008  a   1.15 ± 0.24     a 0.42 ± 0.08   ab 
 Ag+nHA 0.82 ±  0.08  c  0.12 ± 0.04 b  21.89 ± 5.07  ab 14.37 ± 3.73 bcd 
 Ag+mHA 0.63 ±  0.03  d  0.09 ± 0.02 a  22.23 ± 3.91  ab 11.88 ± 1.90 bcd 
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3.3.5 Re-investigating the antibacterial activity of anodized groups and silver 
plated discs 
 
The turbidity measurement for the external media from the Ag and TiO2+nHA discs 
were significantly lower than the control, indicative of growth inhibition (Kruskal- 
Wallis, p = 0.02). While absorbance in media from TiO2 and TiO2+mHA discs did not 
show any difference with the control group (Figure 3.9A). Likewise, the results of 
lactate production showed a significant decrease in bacterial growth in the external 
media of Ag and TiO2+nHA compared to control Ti discs (Figure 3.9C and E). The 
data of the live/dead assay normalized to the control; Ag and TiO2+nHA showed 
almost 50 % decrease in bacterial growth compared to control uncoated discs (Ti). 
The results of turbidity and lactate production showed a significant decrease in 
bacterial attachment to Ag discs compared to the control Ti disc (Kruskal-Wallis, 
p<0.001). In contrast the anodized groups showed no significant difference with the 
control (Figure 3.9B and D). There was full bacterial growth on the three groups of 
anodized discs. Likewise, the live/dead showed bacterial growth inhibition on silver 
plated discs, whereas the anodized groups did not show any growth inhibition of the 
attached bacteria (Figure 3.9F). 
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Figure 3.9 the Growth of S. sanguinis in the external media and on the discs. A) Bacterial growth of S. 
sanguiuis in external media of different coated titanium discs, measured as absorbance values (one 
way ANOVA, p = 0.01)  B) the turbidity measurement of the attached bacteria to different coated 
titanium discs after 16 h incubation (Kruskal-Wallis, p = 0.001), C) the lactate production in the 
external media (Kruskal-Wallis, p = 0.03), D) lactate production of the attached bacteria (Kruskal-
Wallis, p = 0.0005), E) the percentage of live S. sanguinis normalized to control uncoated disc in the 
external media (Kruskal-Wallis, p = 0.03), F) the percentage of live S. sanguinis normalized to control 
(uncoated disc) attached to the different coated discs (Kruskal-Wallis, p = 0.009), different letters 
indicate a significant difference between the groups. 
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3.3.6 Investigation of the coating stability for the repeated experiment  
 
Inductively coupled plasma optical emission spectrometry (ICP-OES) was used to 
measure the concentration of silver in the media (Table 3.4). Total silver 
concentration (in mg/l) for the silver coated discs was 0.112 ± 0.044 in the external 
media. The silver concentration for Ti discs was below the detection limits (< 4 µg/l). 
A low concentration of silver was also noticed in the anodized groups. Silver 
concentration was 0.067 ± 0.023, 0.038 ± 0.004, and 0.015 ± 0.005 mg/l in TiO2, 
TiO2+nHA and TiO2 ± mHA respectively (mean ± S.E.M). Sonicated media on the 
other hand showed a higher silver release for silver plated discs compared to the 
external media, as the silver concentration in sonicated media for silver plated discs 
was 1.07 ± 0.482 mg/l. The concentration of silver for the remaining groups, 
including control uncoated discs, was below the detection limit (< 9 µg/l). Table 3.4 
also shows the concentration of calcium in external media, there was a significant 
difference in the concentration of calcium between the groups (Kruskal-Wallis, p 
<0.005). It is apparent from Table 3.4 that the concentration of calcium for TiO2+nHA 
and TiO2+mHA in sonicated media is higher than the other groups (Kruskal-Wallis, 
p<0.005). The concentration of phosphorus in external media showed negligible 
variation between the groups, and sonicated media showed a significant difference 
between those discs coated with hydroxyapatite micro/nanoparticles and the other 
groups (ANOVA, p<0.001), as the concentration of phosphorus was higher in 
hydroxyapatite coated discs. 
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External media: the concentration of the coating materials in the external media after 24 h, data expressed as means ± S.E.M (n = 6 for each 
treatment). Different letters are statistically different from each other within the column (Kruskal Wallis test, p< 0.001). Sonicated media: the 
concentration of the coating materials in the media after sonication for 1 min. data expressed as means ± S.E.M (n = 6 for each treatment). 
Different letters are statistically different from each other within the column (Kruskal- Wallis test, P < 0.05). 
Table 3.4 Total Ag, Ti, P, and Ca (mg/l) released from the discs to the external media after 24 h and to the sonicated media after 1 min. sonication. 
 Treatment    Materials  in mg/l     
Ag  Ti  P  Ca  
External media Blank  0.00 ± 0.00   a  0.01 ± 0.00  a  104.00 ± 1.9        a 61.73 ± 0.24  a 
 Ti 0.00  ± 0.00  a  0.14 ± 0.01  b  100.04 ± 2.2   ab   64.30 ± 0.80  ab 
 TiO2 0.06 ± 0.02   bc  0.08 ± 0.01  c  96.11 ± 2.15    bc 59.20 ± 0.91  a 
 TiO2+nHA 0.03 ± 0.00   ab  0.01 ± 0.00  ad  86.17 ± 2.98    d 35.37 ± 8.25  c 
 TiO2+mHA 0.01 ± 0.00   ab  0.07 ± 0.01  c  101.47 ± 4.47  ab 74.64 ± 5.56  b 
 Ag 0.11 ± 0.04   c  0.03 ± 0.00  d  91.55 ± 0.55    cd 45.71 ± 4.26  c   
Sonicated media Ti 0.009 ± 0.00  a  0.00 ± 0.00   0.91 ± 0.29 a 1.54 ± 0.13 a 
 TiO2 0.005 ±  0.00 a  0.00 ± 0.00   1.32 ± 0.28 a 2.01 ± 0.30 a 
 TiO2+nHA 0.01 ±  0.00  a  0.02 ± 0.01   3.30 ± 0.46 b 5.58 ± 0.54 b 
 TiO2+mHA 0.01 ±  0.00  a  0.19 ± 0.14   3.85 ± 0.55 b 7.20 ± 1.08 b 
 Ag 1.07 ±  0.48  b  0.02 ± 0.02  0.45 ± 0.15 a 1.32  ± 0.10 a 
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3.4 Discussion 
 
This study was designed to prepare a novel coating for dental implants to prevent 
peri-implantitis; titanium discs were coated with different material by various 
techniques and their antibacterial activity examined against S. sanguinis. The main 
findings were that some of the coating techniques were successful with some draw 
backs. The metal composition of the surface was confirmed by SEM/EDS. 
Furthermore, the silver plated groups showed good antibacterial activity. Among 
them, silver plated discs coated with hydroxyapatite nanoparticles (Ag+nHA) were 
the best, as they show antibacterial activity against suspended bacteria as well as 
the attached bacteria. However there was some silver release into the media. The 
uncoated and anodized groups did not show any antibacterial activity against S. 
sanguinis. In contrast, hydroxyapatite coated discs (nHA and mHA) provided a 
favourable condition for bacteria to attach to the titanium discs. Table 3.5 Shows the 
antibacterial activity of the coatings according to the assays that used in the study. 
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 refers to the coatings that showed bacterial growth inhibition, X refers to the coatings that did not show any bacterial growth inhibition.
Table 3.5 The antibacterial activity of the different coated discs against S. sanguinis according to the assays used in the study 
 
Treatments 
Turbidity 
assay 
Lactate production 
assay 
Live dead assay 
Scanning electron 
microscopy images 
uncoated disc (Ti) 
X X X X 
Hydroxyapatite nanoparticle coated (nHA) 
X X X X 
Hydroxyapatite microparticle coated (mHA) 
X X X X 
Anodized disc (TiO2)  
X X X X 
Anodized disc coated with hydroxyapatite 
nanoparticle (TiO2+nHA) X X X X 
Anodized disc coated with hydroxyapatite 
microparticle (TiO2+mHA) X X X X 
Silver plated disc (Ag)     
Silver plated disc coated with hydroxyapatite 
nanoparticle (Ag+nHA)     
Silver plated disc coated with hydroxyapatite 
microparticle (Ag+mHA)     
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3.4.1 Surface characterization 
 
The roughness of the coated discs was investigated, because roughness might have 
an effect on the ability of bacteria to colonize on titanium discs. The roughness more 
than 10 µm increase the risk of peri-implantitis (Le Guéhennec et al., 2007).The 
results revealed that silver plating and anodization retained the roughness of the 
titanium discs at the nanometer scale (Table 3.2). While the hydroxyapatite 
microparticle coatings increased disc roughness. This result could be explained by 
the fact that hydroxyapatite microparticles tend to produce clusters (Onuma et al., 
1998) with different sizes on titanium surfaces; which make the surfaces irregular 
comparing to the control uncoated discs. Nonetheless, the roughness of the discs 
was still in the 1- 2 µm range, which will not enhance bacterial growth. It has been 
stated by Le Guéhennec et al. (2007) that roughness below 2 µm will limit peri-
implantitis. 
Scanning electron microscopy was used to investigate the morphology of the 
coatings. It showed that the silver plating method formed an evenly distributed silver 
layer in a nanocrystalline form (Figure 3.3B); with their diameter estimated to be 
between 25-50 nm. It is encouraging to compare this figure with that found by Lin et 
al. (2011), who found that silver plating will lead to formation of particles with a grain 
size of less than 25 nm. Moreover, the deposition and heating method for both 
hydroxyapatite microparticles and nanoparticles was also successful with some 
shortcomings. It led to the formation of a thick layer of hydroxyapatite microparticles 
or nanoparticles on the surface. However this method has some drawbacks, as 
some cracks were noticed on those discs coated with hydroxyapatite nanoparticles 
(Figure 3.2). This may perhaps be due to the thermal expansion mismatch between 
the coating and the metal substrate, which generates an internal stress at the 
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coating-metal interface to cause micro cracking (Li et al,. 2009). Jarernboon et al. 
(2009) assumed that the difference in the thermal expansion coefficients between 
the substrate and the deposited particle will cause cracking on the surface. The 
cracks only happened in discs coated with hydroxyapatite nanoparticles rather than 
hydroxyapatite microparticles (Figure 3.2), because hydroxyapatite in the nanophase 
has a higher surface energy and produces a continuous coating on the titanium 
surface rather than clusters. Subsequently, during the drying step of the coating 
process, the shrinkage of the coating causes some cracking. This explanation 
corroborates the ideas of Mahé et al. (2008), who suggested that the drying step is 
responsible for cracking. In the case of hydroxyapatite microparticles, the cohesion 
between the particles and substrate is weaker, hence the particles can migrate and 
form clusters while the water molecules escape. For that reason the hydroxyapatite 
coated discs of all groups showed uneven distributions of the hydroxpatite 
microparticles. 
3.4.2 Antibacterial activity of the different coatings 
 
The results of the turbidity and lactate production assay confirmed antibacterial 
activity of silver plated groups against S. sanguinis in suspension (Figure 13). There 
are two possible explanation for this; either it is due to silver ion release or the direct 
contact of the microbe with the silver nanoparticles (Liao et al., 2010). The former is 
more likely, because the ICP-MS results showed silver ion release from the discs to 
the external media (Table 7). It is assumed that the potency of silver is related to its 
active form (soluble silver ion). Schreurs et al. (1982) found that the silver ion 
interfere with the integrity of bacterial membrane. Damm et al., (2008) stated that 
silver ions can bind to the electron donor groups in biological molecules containing 
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sulphur, oxygen or nitrogen, which cause defects in cell membrane and bacterial 
death.    
It was also found that the silver plated groups had anti-biofilm activity and can 
decrease the colonisation and attachment of the bacteria to the discs (Figure 3.6 B 
and D). There are two possible mechanisms to explain the anti-biofilm activity of 
silver plated groups, the bacteria have been killed in the suspension before settling 
down due to the effect of the silver that have been released to the media (Table 3.3), 
which support the above hypothesis. Another explanation for the anti-biofilm effect 
could be due to the direct bacterial contact with the silver nanoparticles, because 
silver nanoparticles have a large specific surface area to interact with bacteria (Feng 
el al., 2000). It was confirmed by SEM that the silver coating produced by silver 
plating seems like silver nanoparticles (Figure 3.3B). The direct contact of silver 
nanoparticles with bacteria may result in bacterial membrane rupture as suggested 
by Lok et al. (2006). Furthermore, Sondi et al., (2004) revealed that AgNPs can 
accumulate in the bacterial membrane and increase the permeability of the cell wall; 
this will lead to loss of cell content and bacterial death. Furthermore, it was found 
that the Ag+nHA discs showed the highest anti-biofilm activity among all the tested 
groups (Figure 3.6B and D). This is probably due to the silver release for those discs 
as shown in (Table 3.3). this finding is in accordance with the previous study done by 
Chen et al. (2007), who found that the low silver release from silver containing 
hydroxyapatite reduce the bacterial growth. Another explanation could be due to the 
effect of heating step in coating process, which led to activation of silver through 
reacting with hydroxyl group of hydroxyapatite to form silver oxide. Scales et al. 
(1984) stated that heating of silver to above 180 °C can activate bioerodible silver 
components.  
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It was noticed that all the anodized groups showed antibacterial and anti-biofilm 
activity (Figure 3.6C and D). It seems possible that this finding is due to the 
contamination of anodization solution with silver (Table 3.3), because anodization 
technique will thicken the oxide layer of the titanium that has no antibacterial activity.  
In order to check whether this antibacterial activity is because of anodization or the 
silver contamination, the experiment was repeated again by using new anodized 
discs that were prepared in fresh uncontaminated solution (section 3.4.3).  
The results of lactate production assay (Figure 3.6C and D) showed a full growth 
on nHA and mHA discs in the external media and in the media obtained from 
sonicated discs. This suggests that hydroxyapatite has no antibacterial activity 
against S. sanguinis, but enhances their growth instead. This finding further supports 
the idea of Rameshbabu et al. (2007), who assumed that hydroxyapatite can absorb 
many proteins, amino acids and other organic materials which favour the attachment 
and colonization of bacteria. Contrary to the lactate production assay result, the 
turbidity and live/dead results showed less bacterial growth in external media of nHA 
and mHA compared to the control (uncoated disc, Figure 3.3A). This is possibly 
because most of the bacteria were removed from the media of hydroxyapatite coated 
discs during their collection. Nevertheless, this effect was not reflected  in the results 
of the lactate production assay, because the lactate released early on and remained 
in the media. 
The results of the lactate assay and turbidity measurements for the control discs 
showed a limited growth in the media after sonication of the discs (Figure 3.3B and 
D). There are two possible explanations for this: either due to the sonication step as 
it was not possible to remove all the bacteria from the discs, or it could be due to the 
smooth surface of the uncoated titanium discs which may decrease the bacterial 
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attachment (Bürgers, 2010). The former seems more likely, because all the 
replicates of control uncoated discs showed full growth in the repeated experiment 
as well as the SEM experiment (Figure 3.6a). Hence an optimization for this step is 
recommended for future work. 
Although the live/dead assay results (Figure 3.3E and F) were in agreement with 
the other two assays (lactate production and turbidity assays), the data values must 
be interpreted with caution, since it was not possible to follow the protocol that is 
recommended by the manufacturer exactly. The calibration curves were not 
performed on the same day as the measurements of fluorescence from the biofilms 
in the experiment, and with differences in the performance of the dyes each day, it 
became clear that calibrations should be done with each use of the dyes in the kit. 
The source of error may be small differences in dye concentration or quenching 
effects each day, which when converted from a calibration curve led to difference in 
the apparent live and dead ratios in the samples. Hence, using the calibration curve 
to the experiment data resulted in negative values. For that reason, the data were 
normalized to control, assuming that the growth of bacteria in the control uncoated 
discs was 100 %.  
The concentration of calcium was measured to investigate the degradation of 
hydroxyapatite; it was difficult to identify whether the calcium and phosphorus are 
from the hydroxyapatite or from the culture media (Table 3.3), as the concentration 
of calcium and phosphorus in the coating were very small compared to their 
concentration in the physiological saline. Furthermore, the concentration of the 
calcium in the external media for those discs that have been silver plated and 
anodized had lower than the expected concentration. This could be as a result of the 
effect of these coating on adsorption of the calcium (Ca2+) from the media (Horie et 
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al., 2009), which led to decrease the concentration of calcium in the media. 
Moreover, coating titanium with hydroxyapatite nanoparticles and microparticles led 
to precipitation of the calcium and phosphorus from the media. This suggestion is 
supported by the results of ICP-MS, which showed higher concentration of calcium 
and phosphorus compared to control discs in the media of sonicated discs (Table 
3.3). Tsui et al (1998) also found that immersion of hydroxyapatite in ringer solution 
(almost the same solution as used in the present study) lead to formation of 
precipitates.  
 
3.4.3 Repeat experiment for anodized group using uncontaminated anodization 
solution 
 
The results of the repeated experiment showed that anodized discs have neither 
antibacterial nor anti-biofilm against S. sanguinis; suggesting that the reason for 
killing bacteria at the first run of the experiment was due to silver contamination. On 
the other hand, the external media for Ag discs showed different results from the first 
run of this experiment; they displayed higher bacterial growth compared to silver 
plated discs in the first run of experiment. This may be due to the use of a silver plate 
as the source of silver instead of the silver wire plating process. The surface area of 
silver wire is larger than silver plate; which might have effect on the quality of 
resulted coating on titanium discs. According to the results of the turbidity 
measurements and lactate production assay some of the discs showed full growth 
similar to the control groups, whereas the others showed a reduction or no growth 
(Figure 3.7). This may be related to the amount of silver ion release in the media, as 
silver release was low for those discs that showed high growth of bacteria, while the 
discs with limited growth of bacteria showed high silver release. However this was 
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not the case for the sonicated media. Despite the variation in the silver concentration 
between the discs, all the discs showed antibacterial activity against the bacteria 
(Figure 3.7B and D). The inconsistency in silver dissolution may be because the 
direct application of silver to titanium. Gosheger et al. (2004) assumed that if silver 
was applied directly on titanium, this would cause inconsistency in the silver ion 
dissolution. Hence the sustained release of silver ion cannot be accomplished. 
Nevertheless, the amount of silver that was measured in the media may have had no 
antibacterial effect, as it was lower than the minimum inhibitory concentration of 
silver. This interpretation was confirmed by running a separate experiment to assess 
the MIC of silver nitrate (representing the concentration of silver released from the 
discs to the media) against S. sanguinuis (Appendix D).  
The growth on some of the silver plated discs may be due to resistance to the 
silver ion in the media by some population of these bacteria, through producing a 
kind of mucopolysaccharide by the bacteria (Figure 3.8B). This layer of 
mucopolysaccharide will prevent silver ion reaching the bacteria in the media.  It is 
well known that bacteria use matrix polysaccharides as a protection mechanism in 
biofilms (Van Acker et al., 2014). Kang et al. (2014) stated that the extracellular 
polymeric substance (EPS) produced by bacteria impede intracellular penetration of 
the silver ion, because reducing of sugar content of EPS lead to converting silver ion 
to AgNPs. Stewart et al. (2001) found that there was a subpopulation of bacteria in 
biofilm called persisters, which are responsible for broad resistance including to 
chemicals such as disinfectant.  
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3.5 Conclusion 
 
In the present study, a protocol was developed to produce a coating from silver plate 
and hydroxyapatite nanoparticles, which is suitable to provide a good antibacterial 
and anti-biofilm activity to the surface of dental implants. The evidence from this 
study supports the idea that the antibacterial activity of the silver is not just due to ion 
release, but the direct contact of particles with bacteria also plays an important role 
in its action. However, there is concern about the biological safety of silver releasing 
implantable materials, as there was silver release from the coating. Therefore, 
further in vitro and in vivo studies are needed to investigate the biosafety of this 
coating prior its clinical use.  
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Chapter 4 
Investigating the biocompatibility of silver coating
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4.1 Introduction 
 
Biocompatibility is one of the prerequisite for the safety and efficacy of biomaterials 
that are used to coat the dental implants, as the materials will be in long term 
intimate contact with bone and connective tissues. There is growing interest on using 
metal nanoparticulate such as titanium dioxide, titanium nanotube, and silver, to 
improve the clinical outcome of dental implants. In particular,  many studies focused 
on using silver as a coating for dental implants, since it has a good antibacterial 
activity and reduce perioperative infection (Albers et al., 2013). However, there is a 
concern about the toxic effect of silver against human cells (Cortizo et al., 2004), 
which is mainly due to ion release (Ahamed et al., 2010; Foldbjerg et al., 2009; and 
Greulich et al., 2009). In general, most of the material that used as a coating for 
dental implants will undergo degradation, this is mainly due to the shear force during 
implant insertion, and this will lead to release of metal ion in case of using metal as a 
coating. To determine the biocompatibility of a material, attention should be paid to 
its effect on specific human cells, because the toxicity of the material differs from one 
cell type to other (Cortizo et al., 2004). Hence most of the studies that investigate the 
biocompatibility of the dental implant they used bone or bone like cells such as 
primary human osteoblast, osteoclast, and osteosarcoma cells (Anselme et al., 2000; 
Cortizo et al., 2004; and Albres et al., 2013).  
The aim of this study was to investigate the toxicity of the silver nanoparticle coatings 
that were prepared by electroplating (chapter 3, section 3.2.3) and coated with 
hydroxyapatite nanoparticles, or microparticles, on human cells. For this purpose, 
primary human osteoblast cells were used, since these cells will be in direct contact 
with the coated implants. The objectives were to: (i) investigating the dissolution of 
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the silver by measuring the concentration of the silver in the external media and cell 
homogenate using ICP-OES. Furthermore, to investigate the concentration of the 
electrolytes (K+ and Na+), to check whether there is any change in cell uptake of 
these two electrolytes in the presence of silver; (ii) investigate the cell viability 
qualitatively using light microscopy (Olympus SZ X7 microscope); (iii) evaluate the 
toxicity effect of the silver nanoparticles coatings on osteoblast. The toxicity assays 
such as lactate dehydrogenase activity and protein assays were used, and (iv) to 
investigate the effect of silver on the osteoblast cell functions using the alkaline 
phosphatase (ALP) activity assay. ALP is commonly used as a biomarker to evaluate 
the metabolic activity of bone. This is because it plays an important role in the 
mineral formation by bone cell, due to its effect on both the increase of the local 
concentration of inorganic phosphate (mineralization promoter) and decrease of the 
extracellular pyro phosphatase which is mineralization inhibitor (Golub et al., 2007).  
4.2 Methodology  
4.2.1 Cell culture 
 
Primary human osteoblast cells (Hob) obtained from ECACC (European Collection of 
Cell cultures) were cultured at a density 1 x 106 in 75 cm2 flasks (Sterilin, Newport, UK) 
containing 15 mL of DMEM (Dulbecco’s Modified Eagle’s medium) with L-glutamine, 
10 % foetal bovine serum (FBS), and 1 % penicillin-streptomycin (100 IU Penicillin- 100 
μg/ml Streptomycin) purchased from Invitrogen. The media were routinely changed 
every 3 days and the cells sub-cultured when confluence reached 80-85 %. For sub-
culturing, the cells were washed twice with phosphate buffer saline, D-PBS, (Fischer 
scientific, without added calcium and magnesium), then tryptinized (2 ml of 0.25% 
trypsin and EDTA) and resuspended in fresh media and counted with haemocytometer. 
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The cell viability was checked with trypan blue. All cells were kept in 37 °C in 5 % CO2 
and 95 % air; passage 5 was used for the experiment below. 
4.2.2 Experimental design 
 
The biosafety of the silver plated discs coated with hydroxyapatite nanoparticles or 
microparticles (Ag+nHA, and Ag+ mHA) were investigated. Briefly, sterile coated 
titanium discs were placed in 24 well microplates and 20000 cells/ml media were 
added (n= 9 per treatment each 3 replicates in one plate) and incubated for 72 h. Two 
control groups were used in this experiment; uncoated titanium discs (Ti), and a 
reference control (media + cells without titanium discs which are referred as the “blank” 
hereafter). The media were replaced with fresh media every 24 h; and the removed 
media was used to determine the lactate dehydrogenase activity (LDH), alkaline 
phosatase activity (ALP), and measuring the total silver and electrolytes (K+, Na+) 
concentration by ICP-OES.  
At the end of incubation period (72 h), the external media was removed from each 
well and the cells were washed twice with sucrose buffer (300 mmol/l sucrose, 0.1 
mmol/l EDTA, 20 mmol/l HEPES buffered to 7.4 with few drops of trizma base), then 1 
ml of lysis buffer was added to the well (as the washing buffer above except the 
concentration of sucrose was 30 mmol/l (hypotonic) and 0.01 % of Triton-X was also 
added to facilitate the detachment of cells from the well). The cell homogenate were 
further diluted in milliQ water, to minimize the effect of Triton-X on the enzyme activity 
measurements. After that, the cell homogenate was sonicated for a few seconds. The 
cell homogenate were used to measure cellular LDH activity, ALP activity, protein 
content using BCA, and metal analysis (n = 6 per treatment).  
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 Photographs were also taken for the cells after 72 h exposure (n = 3 plates). For 
this, the media were removed and the cells were washed with sucrose buffer. The 
cells were then fixed with 100 % ethanol for 3 min and stained with Harris’s 
Haematoxylin and Eosin (H & E). The cells were examined using a dissection 
microscopy (Olympus SZ X7).  
4.2.3 Lactate dehydrogenase assay 
 
In order to measure the toxicity or cell injury caused by silver, the LDH activity in the 
media was measured at 24, 48, and 72 h. In addition LDH was also determined in the 
cell homogenate after the cells were lysed with lysis buffer to measure the leakage of 
LDH from inside the cells. The assay was performed following the protocol of Plummer 
(1971). For the assay, 1 ml of reagent assay (0.6 mM of pyruvate in 50 mM phosphate 
buffer at pH 7.5) was added to a 1 ml cuvette, and then 0.035 µl of 0.6 mM of NADH 
was added to the mixture, and 0.035 µl of the test sample (cell culture media/ cell 
homogenate) was added at the end and mixed quickly with a paddle. The oxidation of 
NADH was followed at 340 nm (Helios β Spectrophotometer, manufacturer, England) 
for 2 minutes. The LDH activity (µmol/min/ml) was calculated using extinction 
coefficient of 6.3 mM for a path length of 1 cm. The intracellular LDH was normalized 
with intracellular protein content (µmol/min /mg protein).   
4.2.4 Protein assay 
 
The Bicinchoninic acid (BCA) method was used to measure the protein concentration 
of homogenates (MC155208, Pierce, Rockford, USA). After the cells had been lysed, 
10 µl of the cell homogenate was added to 190 µl of BCA reagent in 96 well plates. 
The plate was incubated in a 37 °C incubator for 30 min, and then the absorbance was 
read at 562 nm (VersaMax, molecular devices, Berkshire, UK). A series of bovine 
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serum albumin standards (1.25, 0.625, 0.312, 0.156 and 0 mg/l) were used for 
calibration (Appendix E). 
4.2.5 Alkaline phosphatase activity 
 
 The activity of alkaline phosphatase (ALP) enzyme was measured in the external 
media and the cell homogenate, in order to check the effect of the silver coatings on 
osteoblast function. In brief, 0.065 µl of the sample (external media or cell homogenate) 
was added to 0.665 of the reagent assay (0.265 ml of 0.1 M glycine buffer + 0.330 ml 
of 0.5 mM p-Nitrophenylphosphatase (pNPP) in glycine buffer). The appearance of p-
Nitrophenol was measured spectrophotometrically at 405 nm (Helios β 
Spectrophotometer, manufacturer, England). ALP activity was calculated using an 
extinction coefficient of 18.3 mM for a path length of 1 cm. The intracellular ALP 
activity was expressed as mmol/min/ml for the external media and mmol/min/mg cell 
protein for cell homogenate.   
4.2.6 Statistical analysis 
 
All data are expressed as mean ± S.E.M and analysed using Stat Graphic version 5.1. 
The differences between the treatments and controls within a day were evaluated 
using one way ANOVA. Parametric data were tested by one way ANOVA, and non-
parametric data analysed by Kruskal-Wallis. Two way ANOVA was used to assess the 
time and treatments effects. p values equal or less than 0.05 was considered to be 
significant.  
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4.3 Results 
4.3.1 Investigating the silver exposure of the osteoblast cells 
 
Total silver concentrations were measured in the external media on days 1, 2, and 3 
(Table 4.1). There was a significant difference in silver concentration between the 
groups (Kruskal- Wallis, p < 0.05). The highest concentration of silver was observed 
after one day in the external media of the Ag+nHA and Ag+mHA treatments; the 
concentration of silver (in mg/l) was 10.99 ± 1.32 and 7 ± 1.53 in Ag+nHA and 
Ag+mHA respectively. At day 2 and day 3, the total silver concentration was lower 
compared to day 1 (Table 4.1). The concentration of silver in the control (blank) was 
below the detection limit (detection limit < 0.04 mg/l). Media from the uncoated Ti discs 
showed a low concentration of silver (0.06 mg/l) on the first day, while in second and 
third days it was below the detection limit. In the cell homogenate (Table 4.2), the 
concentration of silver in the control groups was below detection limit. The 
concentration of silver in the Ag+mHA and Ag+nHA discs was statistically higher than 
the blank (Kruskal-Wallis, p = 0.0005). The electrolytes, Na+ and K+, were also 
measured in the external media and cell homogenate (Tables 4.1 and 4.2); there was 
no significant difference between the treatment and control in the electrolytes 
concentrations except in the  day 1, where the concentration of Na+ in the treatments 
was higher than the blank (Table 4.1).   
 
 
 
 
 99 
 
Table 4.1 The total concentration of Ag (mg/l)  and electrolytes,  Na+, and K+ (in mmol/l) in the media after 
exposing osteoblast to silver coatings over 72 h. 
 Treatment Day 1 Day 2 Day 3 
Silver blank 0.04  ± 0.00   a 0.01  ± 0.00     a * 0.01 ± 0.00   a * 
 Ti 0.06  ± 0.01    a 0.01  ± 0.00     a * 0.00 ± 0.00   a * 
 Ag+nHA 10.99  ± 1.32  b 10.34 ± 1.60    b 2.31 ± 0.60   b *# 
 Ag+mHA 7.83  ± 1.53    c 5.02 ± 1.07      c 3.47 ±   0.50 c * 
Sodium blank 128.00 ± 15.00     a 162 ± 0.9   * 156 ± 14 * 
 Ti 163.00 ±  11.00    b 161 ± 4.7    161 ± 16   
 Ag+nHA 166.00 ±  7.70      b  160 ± 3.2      152 ± 8.2  
 Ag+mHA 179.00 ±  6.30      b 170 ± 4.5    157 ± 3.6     
Potassium   blank 10.50 ±  0.66   10.30 ± 0.11 ab * 9.90 ± 0.96   *   
 Ti 10.30 ±  0.97   10.20 ± 0.28  a 10.30 ± 1.20      
 Ag+nHA 10.60 ±  0.59   10.30 ± 0.30   ab 9.90 ± 0.62     
 Ag+mHA 11.30  ±  0.46   11.00 ± 0.28      b 10.00 ±  0.28      
Data expressed as means ± S.E.M (n = 9 for each treatment). Different letters are statistically different 
from each other within the column. * Significant different from day 1 within row, # significantly different 
from previous end point within row (one way ANOVA or Kruskal- Wallis test, P < 0.05). 
 
 
 
 
4.3.2 Investigation of cell morphology 
 
Table 4.2 The total concentration of Ag in mg/l, Na+, and K+ in mmol/l the cell homogenate after 72 h 
Concentration on mg/l for silver and mmol/l for Na
+
 and K
+
 
 Ag  Na  K   
 
 
blank 0.02  ±  0.01   a  0.98 ± 0.10      0.39 ±  0.02   ab  
Ti 0.02  ±  0.00   a  1.00 ± 0.28     0.30  ±  0.05   a 
 Ag+nHA 0.34  ±  0.07   b  1.16 ± 0.16      0.61  ±  0.03   b 
 Ag+mHA 0.42  ±  0.23   b  1.40 ± 0.30      0.25   ± 0.02   a 
Data expressed as means ± S.E.M (n = 6 for each treatment). Different letters are statistically 
different from each other within the column (Kruskal- Wallis test, P < 0.05) 
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The morphology of the Hob cells were investigated after incubating with the titanium 
discs over 72 h (Figure 4.1). The blank showed a high density of osteoblast cells, with 
a normal nucleus and elongated cytoplasm. While a lower density of cells was 
observed in the uncoated control discs. Furthermore, the cells showed shrinkage in 
cytoplasm on uncoated control discs (Figure 4.1 B). The Ag+nHA and Ag+mHA discs 
did not show any cells on their surfaces (Figure 4.1 C and D). Moreover, Ag+nHA 
discs showed a precipitation of discs which is either the aggregates of nanomaterials 
( Ag and HA) or cell debris. 
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Figure 4.1 Morphology of osteoblast cells after 72 h exposure to silver. Dissection microscopy (Olympus SZ X7) (n = 3) scale bar = 10 µm. Osteoblast 
cells stained with Haematoxylin and Eosin grown on (A) 24 well microplate (reference control) (B) uncoated titanium disc, (C) silver plated disc coated 
with hydroxyapatite nanoparticles (Ag+nHA), (D) silver plated disc coated with hydroxyapatite microparticles (Ag+mHA).  
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4.3.3 Lactate dehydrogenase 
 
Lactate dehydrogenase release to the media is one of the parameter that indicates cell 
injury. Table 4.3 shows the concentration of LDH (µmol/min/ml) in the external media 
after 24, 48, and 72 h. At 24 and 48 h, the data were not  significantly different 
between any tested groups compared to both control groups (Ti and blank), whereas, 
at 72 h the LDH activity in Ag+mHA was significantly lower than the control groups (Ti 
and blank, one way ANOVA, p = 0.03). Furthermore, both the time and treatments had 
effect on the LDH activity in the media (two way ANOVA, p = 0.006). The activity of the 
LDH was also measured in the cell homogenate, to investigate the cell viability after 72 
h incubation (Figure 4.2). Uncoated control discs (Ti) did not show a statistical 
difference with the reference control (blank). There was a significant decrease in LDH 
activity on Ag+nHA, and Ag+mHA compared to blank (one way ANOVA, p = 0.008). 
However, the silver coated groups (Ag+nHA and Ag+mHA) were not statistically 
different from the uncoated control group.  
Table 4.3 Lactate dehydrogenase activity in the external media (µmole/min/ml) during exposure of 
osteoblast cells to silver coated discs (Ag+nHA and Ag+mHA) over 72 h. 
Treatment Day 1 Day 2 Day 3 
Blank 0.012 ± 0.00 0.014  ± 0.00 0.078 ± 0.01 a *# 
Ti 0.019  ± 0.00 0.032  ± 0.00 0.093 ± 0.01 a *# 
Ag+nHA 0.015  ± 0.00 0.019 ± 0.00 0.065 ±  0.01 ab*# 
Ag+mHA 0.024  ± 0.01 0.015 ± 0.00 0.034 ±  0.00   b 
The data are presented as mean ± S.E.M (n = 9); different letters within column indicate significant 
difference, and absence of the letters means there is no significant difference. * Statistically 
significant difference from day 1 within row. # Statistically different from previous time point within 
row (one way ANOVA, p <0.05). 
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Figure 4.2 LDH activity from cell homogenate after 72 h. Data are mean ± S.E.M (n = 6), 
bars with different letters are statistically different from each other (p< 0.05). 
4.3.4 Protein assay 
 
The concentration of the protein in the cell homogenate was measured after 72 h 
incubation (Figure 4.3). The data did not show any significant differences between 
the control groups (blank and Ti discs) and the silver coated discs (Ag+nHA and 
Ag+mHA) (one way ANOVA, p>0.05). These data were used to normalize the LDH 
and ALP activity of cell homogenate. 
 
 
Figure 4.3 the concentration of protein in the cell homogenate after 72 h incubation. Data 
are mean ± S.E.M (n = 6), one way ANOVA, p>0.05 (no treatment effects). 
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4.3.5 Alkaline phosphatase activity 
 
The presence of alkaline phosphatase in the media indicates the presence of 
metabolically active osteoblast cells. Table 4.4 shows the ALP activity (U/ml) in the 
external media at days 1, 2, and 3. The data did not show any significant differences 
between the groups at day 1, whereas at day 2 uncoated Ti and Ag+mHA discs 
showed decreases in ALP activity compared to the blank (one way ANOVA, p = 0.046). 
At day 3, the ALP activity in Ag+nHA and Ag+mHA discs was lower than the controls 
blank and uncoated Ti disc (one way ANOVA, p = 0.045). After 3 days incubation the 
ALP activity for the cell homogenate was also measured (Figure 4.4). There was a 
significant difference between the treatments and the blank; the ALP activity in the 
treatments (Ag+nHA and Ag+mHA) and uncoated control discs was lower than 
reference control (blank). 
Table 4.4  Alkaline phosphatase activity of the external media in U/ml after exposing the 
osteoblast cells to silver coatings over 72 h 
Treatment Day 1 Day 2 Day 3 
blank 0.009 ± 0.001   0.017  ± 0.004 a 0.016 ± 0.002 a * 
Ti 0.009  ± 0.001  0.011  ± 0.008 b 0.016 ± 0.001 a * 
Ag+nHA 0.010  ± 0.001   0.012 ± 0.005  ab 0.010 ± 0.002 b  
Ag+mHA 0.007  ± 0.001  0.010 ± 0.005   b    0.010 ± 0.002 b     
The data are presented as mean ± S.E.M (n = 9); different letters within column indicate significant 
difference, and absence of the letters means there is no significant difference, * statistically 
significant difference from day 1 within column. # are statistically different from previous time point 
within row (one way ANOVA, p <0.05). 
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Figure 4.4 alkaline phosphatase activity (ALP) from cell homogenate after 72 h. Data are 
mean ± S.E.M (n = 6), bars with different letters are statistically different from each other 
(one way ANOVA, p=0.04). 
4.4 Discussion  
 
This study set out with the aim of evaluating the biosafety of the silver coatings 
(Ag+nHA and Ag+mHA). Primary human osteoblast cells were chosen for this study, 
representing human bone. The main finding was that the presence of the silver in the 
media affected the cell growth, as the osteoblast growth on the silver coated discs was 
lower than in the control (blank). Moreover, it was difficult to detect any cells on the 
surface of the silver coated discs by microscopy. Another main finding was the effect 
of the media on the silver coating stability, because there was high release of silver for 
those discs that coated with silver; in particular in Ag+nHA coating. 
4.4.1 The exposure of the cell and silver accumulation 
 
 Silver concentrations were measured in the external media and cell homogenates 
(Table 4.1 and 4.2) in order to confirm the silver exposure to human osteoblast cells. 
High concentrations of silver were observed in the external media of silver coated 
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discs (Ag+nHA and Ag+mHA), specifically after 24 h incubation and then start to 
diminish in day 2 and 3. Since the dissolution of the metallic materials depends on the 
composition of the biological fluid (Cortizo et al., 2004); it can be argued that the high 
concentration of the silver closely related to the DMEM composition. Possible 
explanation might be the presence of amino acids such as L-Cysteine (63 mg/l) 
enhanced the silver dissolution. This finding can be further supported by the previous 
study by Tsipouras et al. (1995), who found that the presence of cysteine, methionine, 
or glutathione resulted in dissociation of silver sulfadiazine and release of free silver. 
He also mentioned that the serum protein increase the solubility of the silver.  
Furthermore, silver was also observed in the cell homogenate for the treatment and 
controls, the silver accumulation in the cells was observed for the silver coatings. This 
result seems to be consistent with previous research by Arora et al. (2009), who found 
that silver can accumulate in the mammalian cells such as fibroblast cells.  
4.4.2 The effect of silver coatings on human osteoblast cells 
 
The LDH assay was used to measure the cytotoxicity of silver against osteoblast cells. 
The leakage of this enzyme refers to irreversible cell death due to cell membrane 
damage (Fotakis et al., 2006). The results of the LDH in the external media showed 
that the silver has no toxic effect on the cells, because the concentration of LDH in the 
media from the silver coated discs (Ag+nHA and Ag+mHA) was not statistically 
different from the reference control (blank) over 72 h (Table 4.3). This could be due to 
the presence of protein in the media (10 % FBS) that might bind any free silver. Hence, 
the silver is no longer bioavailable to cause toxicity to the cell. Another possible 
explanation could be the interference of the metal ion with the LDH assay, because 
the high concentration of silver in the media. Han et al. (2012) assumed that with 
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increase the concentration of metal nanoparticles in the media the LDH activity will 
decrease; by providing more surface area for LDH adsorption.  
In contrast, the cell homogenate showed a low level of LDH activity in the silver coated 
disc treatments compared to the reference control (blank, Figure 4.2), which 
apparently infer  less number of viable cells on the surface of silver coatings. It seems 
possible that the concentration of the silver in the media was at a sublethal dose; as 
the silver did not kill the cells but prevents the proliferation of the cells. This result is in 
accordance with a research done by Pauksch et al. (2014), who showed that 10 mg/l 
of silver will impair the proliferation of osteoblast cells. Albres et al. (2013) also 
confirmed the toxicity of the free silver ions to human osteoblast cells in concentration 
of > 5 mg/l. The possibility of a reduction in LDH activity due to silver interference 
seems unlikely because  the concentration of silver in cell homogenate was much 
lower than in the media.   
The mechanisms underlying the toxic effect of silver to human cells is not fully 
understood, and whether the ions or the particles themselves will cause the toxicity. 
Hsin et al. (2008) assumed that silver nanoparticle enhance mitochondria-dependent 
apoptosis of the cells, through increasing the production of intracellular reactive 
oxygen species. While, Park et al. (2010) related the toxicity of the silver to the free ion 
release. Furthermore, Kone et al. (1988) stated that silver ions can exert toxic effect to 
human cell; through changing the permeability of the cell membrane to K+ and Na+. 
However, the results did not show any significant difference in the concentration of K+ 
in the cell homogenate compared to control group. 
The viability of the cells was also evaluated qualitatively using dissection microscopy; 
contrary to expectation, the microscope images did not show any cell on the silver 
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coated discs (Figure 4.1C and D). Since this finding is not in accordance with the 
results of the LDH, alkaline phosphatase, and protein assay, is it possible that the cells 
detached during staining steps. One explanation would be that the attachment of the 
cells to the surface of silver coated discs is very weak compared to uncoated control 
disc, and the cells could therefore easily detach from the surface. Another explanation 
for this could be the interference of the stain with coatings which lead to cell 
detachment. It is difficult to provide the exact answer for this, as this technique has not 
been used often for this type of experiments. Hence, more investigations are needed 
before using this technique in future. 
Alkaline phosphatase enzyme was also measured, because it is considered as an 
important biomarker to evaluate the activity of the bone cells. The activity of this 
enzyme infers a healthy cell that has ability to form a new bone. The results showed 
that the activity of alkaline phosphatase was not affected by the presence of silver in 
the media (Table 4.4), which apparently means that silver has no adverse effect on the 
ability of the osteoblast to work properly. This finding is consistent with study done by 
Pauksch et al. (2014), who found that silver at sublethal dose (10 mg/l Ag) will not 
inhibit alkaline phosphatase activity in human osteoblast cells. In contrast the results 
for cell homogenate (Figure 4.4) showed a decrease in the activity of this enzyme 
compared to blank, which means that silver impaired the activity of osteoblast to form 
new bone. This result supports the previous research done by Chen et al. (2007), who 
found that silver containing hydroxyapatite (1.5 % silver) will decrease the alkaline 
phosphatase activity of osteoblast like cells. Nevertheless, any protein based assay 
should be interpreted with caution, due to the ability of silver to interact with proteins 
and enzymes in mammalian cells (Panyala et al., 2008). 
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4.5 Conclusion  
 
The purpose of the current study was to determine the biocompatibility of the silver 
coatings (Ag+nHA and Ag+mHA) against human osteoblast cells. One of the more 
significant findings to emerge from this study is that the coatings caused toxicity to the 
human cells and decreased their viability. Contrary to the result of chapter 3 as the 
silver coatings showed  low silver degradation in physiological saline media ( section 
3.3.3), the degradation of silver coatings was very high in the DMEM, which led to high 
silver ion release. Hence, these coatings are not yet ready to be used for clinical 
purposes; further studies are needed to investigate the cause of the silver release in 
this specific media, and the exact mechanism of how the silver cause the reduction in 
cell viability. 
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Chapter 5  
General Discussion 
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There is an  increase in the use of dental implants worldwide; but the infection 
associated with the implants is one the common causes of their failure; for which 
there is no ideal treatment so far. The current study mainly aimed to prepare a 
coating for the dental implant, which can prevent peri-implantitis without causing 
toxic effect to the human cells. This first goal was achieved, by preparing a coating 
consists of two layers, which composed of silver and hydroxyapatite nanoparticles or 
microparticles. It is confirmed that the coating had antibiofilm effect against S. 
sanguinis. Furthermore, the silver ion release was controlled and low. However, their 
effect on the osteoblast preservation poses a major problem, because the osteoblast 
viability decreased by 60 % compared to uncoated titanium discs. This possibly was 
due to the high silver ion release in cell media. Hence, this issue could be 
considered before going any further to use this kind of coating clinically on the 
patient.   
5.1 The toxicity of the silver coating to the bacteria compared to human cells 
 
 In this study both antibacterial activity and biocompatibility was investigated for 
these coatings that consisted of, silver and hydroxyapatite nanoparticles or 
microparticles. The antibacterial investigation showed a promising outcome for better 
dental implant coatings. This is because the silver coatings were able to reduce the 
bacterial growth on the titanium discs, with very low silver ion release.  This type of 
coating may therefore be developed for clinical applicationsin the future. However, to 
use this type of coating clinically, their toxicity to human cells should be investigated. 
Hence, the human osteoblast cells were used to evaluate the toxicity of these 
coatings in vitro. The outcome of this experiment showed that the silver coatings 
reduced the viability of the human osteoblast cells. This effect of the coating on the 
osteoblast was mainly related to the high concentration of the silver measured in the 
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media. In particular, the coating that composed of silver and hydroxyapatite 
nanoparticles. It is interesting to note that the silver release was almost 30 fold 
higher in the cell experiment compared to the bacterial test. This is likely due to the 
difference between the media that was used for growing the bacteria and the cells. 
The composition of the physiological saline was almost the same as the electrolyte 
contents of blood. While DMEM which was used to grow osteoblast cells is more 
complex and contains some surfactants that might have effect on the stability of the 
silver coating. Furthermore, the foetal bovine serum (FBS) might also affect the 
dissolution of the silver. Shi et al. (2012) reported that the presence of serum in the 
media decrease the aggregation of the nanoparticles. It can be suggested that the 
media used to grow the bacteria was more relevant to the condition that the coating 
will be expose to in the patient’s mouth.  
5.2 Clinical perspectives 
 
In order to translate any medical products to the clinic, several regulatory steps  
should be followed. Several criteria should be met by any new medical products in 
order to be approved clinically, which are: (i) the efficacy of the medical product, to 
demonstrate whether it works and gives a benefit to the patient’s health, (ii) to prove 
that the new product it more effective for its purpose than the already existing 
product, and (iii) finally and most important, is to ensure the biosafety of the product 
for its use with patients. These criteria have been placed by health agencies such as 
the European Medicines Agency (EMA) in Europe, and the Food and Drug 
Administration (FDA) in the United States (Juillerat-Jeanneret et al., 2013). The 
coating that developed reaches some of these criteria in term of its efficacy to 
eradicate the biofilm formation on the current implant surfaces; this will decrease the 
infection associated with dental implants and can replace the dental implants that are 
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in use nowadays. However, an issue that remains to be resolved, is the toxic effect 
of this coating to the human osteoblast cell. Nevertheless, approval might eventually 
be achieved by considering that the concentration of silver that kill the bacteria was 
much lower than that causing toxicity to the human cells. Improving the stability of 
the silver coating by decreasing its dissolution in different biological solutions may 
help achieve the desired outcome of biocompatibility. Regardless, hydroxyapatite in 
both forms (nanoparticles and microparticles) did not show any difference in 
biocompatibility, but the hydroxyapatite nanoparticles showed a better antibiofilm 
effect. Hence, it will be beneficial to develop the coating that composed of silver and 
hydroxyapatite nanoparticles.   
5.3 Limitations of the study 
 
This study has a number of limitations that should be considered in the future, some 
of these limitations  are listed below: 
1- Using dissection microscopy to investigate the cell viability has some limitation, 
because it was difficult to visualise any cells on silver plated discs. This could be due 
to the interaction of the coating materials and the stains. 
2- Assessing the bacterial growth using a turbidity assay was problematic due to the 
natural turbidity of the nanoparticles. Hence it was difficult to measure the turbidity 
caused by the bacterial growth. Furthermore, this assay does not measure the 
absolute value of the bacterial cells. 
3- It was not possible to use the calibration curve for the live/dead assay, because 
the calibration curve  was performed on a different day.  
4- Protein based assays should be used with caution to measure the cell viability in 
such an experiment, because of the interaction between the protein and silver. 
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5- It was difficult to investigate the degradation of the hydroxyapatite nanoparticles 
and microparticles in dialysis experiment, due to the high concentration of the 
calcium and phosphorus in the physiological saline. 
 
5.4  Future work 
 
A number of areas need further investigation and some of them are listed below: 
1- Further studies are required to investigate the mechanism by which S. sanguinis 
produces mucopolysaccharide, and to what extent this mucopolysaccharide can 
protect the bacteria from silver ion exposure. Another question arising is why some 
populations of the microbe can produce the extracellular matrix, whereas the other 
population cannot. 
2- Investigating the antibacterial of the coating against only one species is not 
enough to confirm their efficacy. Hence the next step would be investigating the 
antibacterial effect of the coating by culturing more than one bacterial species, which 
are known to cause peri-implantitis such as, Porphyromonas gingivalis, Prevotella 
intermedia, Veillonella species and Treponema denticola. This is because the 
bacteria will act differently together in the biofilm. Furthermore, it would be interesting 
to investigate the antibacterial activity of this coating; by using a biofilm that is taken 
from the real patients. 
3- It would interesting to run the dialysis experiment for the silver in DMEM, for better 
understanding the dissolution of the silver in this particular media. 
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4- It would be interesting to investigate the chemistry of the media to determine 
which factors are critical to silver dissolution, and also evaluating the mechanical 
properties of the coating. 
5- The biocompatibility test was just a preliminary study and need more investigation 
such as standardize the silver release from the coating to the media, and also using 
more specific assays to observe the effect of silver coatings on the osteoblast. 
Another alternative assays also should be used to evaluate the toxicity of the 
coatings. This because there is concern about the validity of protein based assays, 
due to interference of the nanoparticles and metal ions to these kind of assays. 
6- It is encouraging to investigate the effect of the silver on the human cells rather 
than the cytotoxicity. For example, investigating the effect of silver on the expression 
of interlukins and genes in the human osteoblast cells. 
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Appendix A: The growth curve 
 
Figure: The growth curve of Streptococcus sanguinis over 24 h at 37 °C. 
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Appendix B: Lactic acid standards 
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c 
Figure: lactic acid standards for lactate production assay a) for the nanomaterial dispersions 
experiment (chapter 2)  b) disc experiment c) repeated disc experiment (chapter 3). 
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Appendix C: Live/dead calibration curve 
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B 
Figure: calibration curve for live/dead assay A) 24 h calibration curve, B) 16 h calibration curve. 
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Appendix D:  MIC assay 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure: The antibacterial effect of low concentrations of silver nitrate against S. sanguinuis, A) the 
turbidity showed no difference with control, except for 0.3 mg/l was higher than control; this is due 
to the additional turbidity of particles. B) The lactate production assay, there is no growth inhibition 
in any of these concentration (One way ANOVA, P > 0.86). 
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Appendix E: Protein assay 
 
 
 
 
 
 
 
 
 
 
Figure: Standard curve for protein assay 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
